MBA Program in
Health Care Management
2017
RESUME
BOOK
Wharton
Contents
Program Description .......................4
Curriculum ...............................5
Graduates ............................6-32
Internship Sponsors.......................33
Health Care Program Mentors ...........34-37
Administration ..........................37
Faculty ..............................38-39
Thank you for your interest in the Wharton MBA Program
in Health Care Management. For further information,
resumes, and appointments, contact:
June Kinney, Associate Director,
MBA Program in Health Care Management
The Wharton School
University of Pennsylvania
3641 Locust Walk
Philadelphia, PA 19104-6218
215.898.6861 | Fax 215.573.2157
email: [email protected]
For information on the Wharton Health
Care Management Alumni Association, visit
www.whartonhealthcare.org
For detailed information on the Health Care
Management Department educational programs, visit
http://mba.wharton.upenn.edu/healthcare/
M.B.A. Graduates
The University of Pennsylvania was founded by
Benjamin Franklin in 1740. Although the University
carries the name of the Commonwealth, it is not
a state university but an independent, private,
nonsectarian institution. As one of the country’s
earliest educational institutions, it has consistently
initiated advances in teaching and research and
has steadily generated specialized fields of higher
education. Penn, as the University is commonly
known, was the first American university to form
departments of botany, hygiene and public health,
surgical research, and research medicine. The
University School of Medicine, formed in 1765,
was the first in North America, as was the teaching
hospital founded in 1874. The world’s first
psychological clinic was opened at Penn in 1896.
The Wharton School, in the same spirit of
innovation and excellence, was the world’s first
collegiate school of business and management.
Founded in 1881 with a gift from Joseph Wharton,
the Philadelphia industrialist and philanthropist,
the Wharton School undertook the pioneer steps
in elevating training for business significantly
above its previous level as noncollegiate commercial
education. In 1921, the formation of the Graduate
Program signaled the advancement of business
administration at Wharton to the highest levels
of professional education.
Today, the Wharton School has more than 270
faculty members teaching in both the graduate
and undergraduate divisions and conducting a
continually expanding volume of research. The
1,700 students in the master’s degree program
may choose from among more than 200 courses
and over 18 majors and concentrations, a variety
reflecting the fact that the Wharton education
complements the career goals of the individual.
This brochure is provided to introduce you to
the 2017 Wharton Health Care Management
Program graduates.
We encourage you to consider these individuals
for employment.
2017
Health Care Management
3
4
The Graduate Program in Health Care Management
is a full-time two-year MBA curriculum offered
by the Health Care Management Department of
the Wharton School. The program, the principal
educational effort at the Leonard Davis Institute
of Health Economics, is designed to provide
managerial and technical expertise to students
interested in the health care management field.
By combining the skills of the Wharton disciplines
with sensitivity to the needs of health care providers
and recipients, the Wharton MBA health care
graduate can effectively manage the delivery of
health services and products at all levels.
The Program has produced graduates who have
chosen careers in hospitals and other medical
institutions, pharmaceutical, biotechnology and
medical device companies, financial services,
entrepreneurial ventures, consulting firms,
insurance firms, private health industry, and
federal, state, and local government. Many
of these MBA graduates now hold positions
as chief executive officers, directors, and other
key decision makers in health care organizations.
The Leonard Davis Institute of Health Economics
(LDI) is an interdisciplinary center for research
and education in the organization, financing,
and delivery of health care. Through LDI, University
of Pennsylvania faculty and staff work together
on issues concerning health policy, health
insurance, managed care, hospitals, corporations,
pharmaceutical companies, and other health-
related organizations. Established in 1967, the
Institute appropriately bears the name of the late
Leonard Davis, one of the foremost innovators in
private health insurance in the United States. He
was the founder of Colonial Penn Group, Inc., a
company that has pioneered in insurance for older
Americans. Both Mr. Davis and Mrs. Sophie Davis
were generous benefactors to the University of
Pennsylvania, contributing basic support for the
activities of the Leonard Davis Institute.
Program Description
5
All students are required to complete the Wharton Management
Core. The Wharton School’s core curriculum is designed to
increase crossfunctional integration, extend global experience,
strengthen leadership training, and introduce new courses
on key management issues. The core curriculum provides
groundwork in basic management disciplines: economics,
finance, financial and cost accounting, management science,
managing people and organizational design, marketing,
operations management, the governmental and legal
environment of business, statistics, and strategy.
Fixed Core:
• Foundations of Teamwork and Leadership
•
Marketing Management
• Quality and Productivity
• Regression Analysis for Business
• Microeconomics for Managers
• Management Communication
Flexible Core:
Accounting
•
Financial Accounting or
• Financial and Managerial Accounting or
• Accelerated Financial Accounting
Finance: Corporate Finance
• Corporate Finance or
• Accelerated Corporate Finance or
• Introduction to Corporate Finance
Finance: Macroeconomics
• Macroeconomics and the Global Economic
Environment or
• Introduction to Macroeconomics and the Global
Economic Environment
Legal Studies & Business Ethics
• Responsibility in Global Management or
• Responsibility in Professional Services
Management
• Managing the Established Enterprise or
• Managing the Emerging Enterprise
Marketing
• Dynamic Marketing Strategy or
• Strategic Marketing Simulations
Operations
• Business Analytics or
• Information Technology and Business Transformation or
• Innovation or
• Operations Strategy
• Communications
• Advanced Persuasive Speaking or
• Advanced Persuasion and Data Display or
• Pitching Your Business
Global Immersion Program
The Wharton Global Immersion Program is an optional
half-credit elective course that provides first-year students
with an in-depth exposure to international business
practices and first-hand insights into a foreign culture.
The Health Care Major Courses and Electives
These courses promote an understanding of concepts,
institutions, and issues
involved in the organization,
financing, and delivery of health services and products
in the United States. Health care electives are selected
consistent with individual career objectives and interests.
Required
• Health Services System
• Health Care Field Application Project
Electives
• Comparative Health Care Systems
• Financial Management of Health Care Organizations
• Managed Care, Market Structure, and
Health Care Delivery
• Health Care Marketing
• Health Care Reform
• Management and Economics of
Pharmaceutical and Biotechnology Industry
• Medical Devices
• Management of Health Care for the Elderly
• E-Health: Business Models and Impact
• Management of Health Care Services Businesses
• Health Care Entrepreneurship
• Private Sector Role in Global Health
• Health Care Services Delivery:
A Managerial Economic Approach
• Advanced Study Project
The Health Care Summer Internship
The internship is a three-month management experience
which provides the health care major an opportunity
to work with a senior executive in an organization of
particular interest to the student.
MBA Electives
Opportunities are available for the health care major
to pursue a second concentration in fields such as entre-
preneurship, marketing, finance, or operations, or to
pursue specialized knowledge in areas such as health care
financing or within specialized segments of the health care
industry including managed care organizations, hospitals,
pharmaceutical and biotechnology companies, medical
device companies, specialty services organizations, and
long term care organizations. Graduate courses are
available throughout the University.
Curriculum
The Wharton Management Core
6
An opportunity to work in a corporate
development or investment role to scale
healthcare businesses.
Medtronic, Minneapolis, MN
Corporate Development Associate,
Summer 2016
Evaluated eight M&A opportunities.
Was responsible for performing
financial valuations, identifying and
quantifying synergies, and designing
earn-out structures to incentivize sell-
ers based on Medtronic operational
objectives. Ran point as lead associate
on two live deals, coordinating M&A
process and aligning stakeholders
across the organization.
Monitor Deloitte, Zurich, Switzerland
Senior Consultant, 2015-2015
Consultant, 2013-2015
Focused on strategy projects in the
Pharmaceutical and Biotech sectors.
Select experiences include conducting
commercial due diligence for M&A
transactions up to $1.1B, crafting
market access strategies for novel
drugs in European and Emerging mar-
kets, and building market forecasts
and scenarios for novel drugs.
Stroud Consulting, Boston, MA
Associate Consultant, 2012-2012
Focused on improving operations of
manufacturing companies. Led teams
of up to eight field engineers and
operators to identify opportunities
for improvement and re-design
manufacturing processes.
Mark Arpels
Amez-Droz
Swiss Federal Institute of Technology (EPFL),
Lausanne, Switzerland
M.Sc., Biological Engineering, 2011
An opportunity to improve patient care
through an operations or strategic role
in healthcare services.
McKinsey & Company, Chicago, IL
Summer Senior Implementation Coach,
Summer 2016
Developed benchmarking standards
for adult and pediatric health quality
metrics in a value-based care program
and created dashboards to calculate
healthcare cost-savings associated with
quality improvements.
Northwestern Memorial Hospital,
Chicago, IL
Operations and Performance Analyst,
2014-2015
Led development of $190M patient
care budgets and constructed dynamic
staffing workbooks utilized by front-
line managers to make daily nursing
staffing decisions. Managed nurse and
technician staffing for 39 units / 1000
FTEs and made hiring recommenda-
tions based on analysis of volume
fluctuations and turnover. Designed
and launched pilot for an innovative
RN float pool program that created
flexible multi-specialty teams.
Cancer Treatment Centers of America,
Schaumburg, IL
Decision Support Analyst, 2013-2014
Management Fellow, 2011-2013
Created interactive departmental
performance dashboards in Qlikview
business intelligence tool for executive
leadership, including a 5-hospital phy-
sician revenue dashboard. Completed
a 2-year accelerated leadership
development program consisting of
rotations in core healthcare business
functions across hospitals and
departments.
Huda N. Almanaseer
Northwestern University, Evanston, IL
B.A., Psychology, 2011
Animesh Agarwal
Indian Institute of Technology Madras,
Chennai, India
B.Tech., M.Tech., Biotechnology, 2009
University of Texas at Austin, Austin, TX
M.S., Biomedical Engineering, 2011
Business development role at
medical device, pharmaceutical
or biotechnology firm.
Medtronic, Minneapolis, MN
Corporate Development Associate,
Summer 2016
Developed an acquisition-based strat-
egy for Medtronic’s entry into renal
care services business in emerging
markets. Participated in high-level
management meetings, including with
CEO Omar Ishrak, to gain approval to
implement this strategy. Negotiated
a $40M supply agreement with India’s
largest private health system.
Ventureast Venture Capital,
Hyderabad, India
Investment Analyst, 2011-2015
Developed investment thesis for
~$100M life-sciences fund; evaluated
~200 life-sciences investment deals,
conducted detailed due-diligence on
10 deals and pitched 4 deals to the
investment committee. Raised $5M
in strategic investment from a pharma
investor for portfolio company with
novel drug delivery mechanism to
treat radiation-therapy side effects
in head and neck cancer patients.
Prepared investment memorandum
and financial model to raise $10M
for a super-specialty prosthetics-clinic
chain.
University of Texas at Austin, Shouval
Computational Neuroscience Lab,
Austin, TX
Research Assistant, 2009-2011
Co-authored 3 peer-reviewed articles
on stochastic analysis of biochemical
networks in neurons responsible for
modulating learning and memory.
7
Simon Basseyn
New York University, New York, NY
B.A., Phi Beta Kappa, Summa Cum Laude,
Politics, 2011
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2017
An opportunity to integrate my clinical
and business experiences to build
leading life sciences companies through
investment, business development, or
operational roles.
SR One, Cambridge, MA
Biotech Venture Capital Intern, Summer
2016
Evaluated company formation and
investment opportunities in microglia.
Advised portfolio companies on strate-
gic decisions. Screened incoming deal
flow and conducted investment due
diligence.
McKinsey & Company, Philadelphia, PA
Summer Associate, Summer 2015
Advised public sector client with a
$20B budget on implementation of
a statewide value-based physician
payment program; oversaw client’s
progress in meeting federal reporting
requirements associated with a
$3M grant; led client workshop on
web-based analytics tool for post-
engagement data analysis and
decision support.
Center for Emergency Care Policy and
Research, University of Pennsylvania,
Philadelphia, PA
Research Fellow, 2014-2015
Co-developed methodology and inter-
preted data as lead or co-author of
studies published in New England
Journal of Medicine, Medical Care, and
Journal of General Internal Medicine,
investigating access to care, patient-
centered medical homes, and health
care reform.
Andrew R. Barnell
Cornell University, Ithaca, NY
B.S., Summa Cum Laude, Applied Economics
& Management, 2011
Helping transform healthcare through
entrepreneurship.
Geneoscopy, St. Louis, MO
Chief Financial Officer, 2015-Present
Defined the company’s business strat-
egy as CFO of a 3-person management
team; managed fundraising, capital
budgeting, business development and
clinical trial execution plan. Raised
$270,000 in capital from investors and
$79,000 from non-dilutive sources.
Planned and executed two clinical
trials; a 12-patient pilot study and a
400-patient validation study.
Lindsay Goldberg, New York, NY
Associate, 2013-2015
Evaluated new investment opportuni-
ties by building financial models, con-
ducting due diligence, managing
advisors and preparing internal invest-
ment committee materials. Managed
portfolio investments by monitoring
monthly financial and operational
performance, analyzing strategic ac-
quisitions, evaluating capital structure
alternatives and collaborating with
management on implementing profit
improvement initiatives.
J.P. Morgan, New York, NY
Healthcare IB Analyst, 2011-2013
Performed valuation analysis using
various methodologies, including: LBO
valuation, DCF valuation, sum-of-parts
valuation, precedent transaction
analysis and comparable trading
analysis. Selected top-tier analyst and
ranked 1st among healthcare invest-
ment banking analysts in 2012 and
2013. Completed 14 total transactions:
3 buy side M&A, 3 sell side M&A, 1
IPO, 5 equity follow-ons, 1 convertible
debt offering and 1 leveraged
recapitalization.
Alexander T.
AuWerter (“Toby”)
Duke University, Durham, NC
B.S., Biomedical Engineering, 2009
An opportunity to use my life sciences
background to help develop and
commercialize new, life changing
therapeutics.
Deloitte Consulting, Philadelphia, PA
Summer Associate, Summer 2016
Managed the creation of a new, enter-
prise-wide R&D organization at a lead-
ing global biopharmaceutical company
(market cap >$150B) along with proj-
ect leadership team. Led workstream
to define vision for operating model,
organizational design, and guiding
principles for new organization.
Juventas Therapeutics, Cleveland, OH
Manager, Field Clinical Operations,
2014-2015
Field Clinical Engineer, 2012 - 2014
Led clinical development activities in-
cluding trial protocol and procedure
design efforts for Phase II HF and PAD
trials, including patient population
selection and endpoint design.
Developed cost effectiveness model,
pricing and evidence generation strat-
egy, and reimbursement framework
for JVS-100 gene therapy.
St. Jude Medical, NY, NY
Senior EP-TSS, 2011-2012
EP-TSS, 2010-2011
EP Field Intern, 2009-2010
Certified in St. Jude’s electrophysiol-
ogy and cardiac rhythm management
product lines. Awarded national sales
award for exceptional account growth.
8
Alessia Bhargava
Yale University, New Haven, CT
B.A., Magna Cum Laude, Economics, 2010
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2017
An opportunity to transform our
mental healthcare system and promote
population mental health globally.
Aledade, Bethesda, MD
Strategic Clinical Initiatives Fellow,
Summer 2016
Created depression toolkit to assist
primary care providers and care man-
agers across 16 Accountable Care
Organizations and 15 states better
treat depression. Analyzed referral
patterns and began formation of care
contracts with high value specialists.
McKinsey & Company, Houston, TX
Business Analyst, 2010-2011
Senior Business Analyst, 2011-2012
Collaborated with ranking military
officers to inspire providers and
medical staff to implement Patient
Centered Medical Homes across Army
Medicine. Held working meetings with
the CEO of a children’s hospital to
amend C-level reporting structures
and re-design accountabilities of top
level roles to incorporate service lines.
Evaluated financial and organizational
synergies in a potential AMC merger;
led analyses to recommend clinical
service line reconfiguration between
4+ hospital sites to achieve >$100MM
in savings.
Publications:
A. Bhargava, X.L. Du “Racial and
socioeconomic disparities in adjuvant
chemotherapy for node-positive oper-
able breast cancer in older women,”
Cancer 2009 (115: 13, 2999-3008).
Rachel L. Belzer
Duke University, Durham, NC
B.S.E., Biomedical Engineering, 2011
An opportunity to improve people’s
lives by building health care products
that are enabled by data analytics and
innovative technology.
Seattle Genetics, Seattle, WA
Market Planning MBA Intern, Summer 2016
Developed and prioritized a lifecycle
plan for an antibody drug conjugate
(ADC) in the company’s pipeline to
capture over 100,000 new patients in
the U.S. based on a quantitative analy-
sis of commercial attractiveness and
ease of development for 17 potential
opportunities. Presented recommenda-
tions to the entire commercial
organization including the EVP of
Commercial and the VP of Marketing.
Deloitte Consulting, Seattle, WA
Consultant, Technology, 2013-2015
Business Technology Analyst, 2011-2013
Technology consultant focused on
digital strategy and data analytics
for healthcare clients, including life
sciences, pharmaceuticals and health
plans. Crafted three-year roadmap of
digital initiatives, providing steps to
implement and sequenced timelines.
Led project to create consistent order
status messaging across web and email
for mail order pharmacy, increasing
customer awareness and decreasing
call center calls by over 7,000 calls per
year. Developed customer data model,
allowing a life sciences client to master
customer data for sales and marketing
strategy.
K. Grace Bell
Case Western Reserve University,
Cleveland, OH
B.S., Management: Health Finance, 2010
An opportunity to grow leading health
care technology and services businesses
through investment.
Rittenhouse Ventures, Philadelphia, PA
Summer Associate, Summer 2016
Led due diligence for 3 Series A invest-
ments within the health care vertical,
including conducting customer
references, analyzing financials and
contributing to the design of all deal
and term documents. Acted as resident
health care industry expert – inter-
preted key market trends and ana-
lyzed and prioritized more than 40
pipeline investment opportunities.
Advised two health technology
portfolio companies to drive strategic
business initiatives regarding market
opportunities and implementation
processes.
NYC Department of Health and Mental
Hygiene, New York, NY
Health System Quality Manager, 2015-2015
Meaningful Use Services Manager,
2013-2014
Implementation Specialist, 2012-2013
Worked with independent providers
and Accountable Care
Organizations to design and imple-
ment quality improvement projects
throughout New York City. Managed
a team to train physicians on over
80 distinct Electronic Health Record
platforms, equaling $13M in federal
grants.
Huron Consulting Group, New York, NY
Clinical Operations Analyst, 2010-2012
Restructured case management and
perioperative departments in four
academic medical centers to improve
alignment, reporting and clinical
practices according to industry best
practice models.
9
Jonathan Cagadas
Northwestern University, Evanston, IL
B.A., Economics & Financial Economics, 2011
University of Pennsylvania, Philadelphia, PA
M.S. Candidate, Computer & Information
Technology, 2017
An opportunity to build new products at
a healthcare technology company.
IBM, Austin, TX
Product Manager Intern, Summer 2016
Led a team of 3 software developers
in building a new use case for IBM
Watson’s predictive analytics platform.
Created a cognitive cloud monitoring
and security tool to prevent cloud
network downtime and disruptions.
Conducted end-user research, deter-
mined product features, led daily
scrums, participated in code reviews,
conducted market and competitive
analysis, and built business plan for
product.
DaVita HealthCare Partners,
Los Angeles, CA
Manager, Corporate Development,
2014-2015
Senior Analyst, Corporate Development,
2013-2014
Analyst, Corporate Strategy, 2011-2013
Transaction manager for DaVita’s
corporate development team, focused
on M&A, JVs, and divestitures in the
physician group sector. Led deal sourc-
ing, valuation, and execution. Involved
in $600M of invested capital and
expanded the company’s physician
group presence into 3 new states.
Prioritized potential growth areas
for the company.
Ramon Burgos
Harvard College, Cambridge, MA
A.B., Government with Language Citation
in Chinese, 2008
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2017
An opportunity to integrate my medical
and business experience to improve
healthcare delivery.
Regeneron Pharmaceuticals,
Tarrytown, NY
Business Operations and Strategic Planning
Intern, Summer 2016
Engaged cross-functional teams across
research, clinical, and finance
functions to establish a business devel-
opment strategy to support Regeneron
Genetics Center research goals in
human genetics and therapeutic
target discovery. Negotiated and
executed two collaborations with
leading academic centers. Presented
recommendations to SVP of Strategy
and other senior commercial leaders.
Brigham and Women’s Hospital,
Boston, MA
Research Assistant, 2010-2012
Team launched patient recruitment
for biobank in support of large-scale
human genetics research. Core respon-
sibilities included: coordinating and
expanding patient recruitment in
multiple clinical settings; obtaining
informed consent; data management;
and preparation of IRB submissions.
Nomura Corporate Research and Asset
Management Inc., New York, NY
Credit Analyst, 2008-2010
Performed investment analysis and
presented recommendations directly
to portfolio managers on corporate
debt investments in the industrial sec-
tor totaling $250M. Responsibilities in-
cluded: construction of financial
models and projections; business risk
assessments; and analysis of credit
agreements.
Sourav Bose
University of Pennsylvania, Philadelphia, PA
B.A., Magna Cum Laude, Biology and B.Sc.,
Magna Cum Laude, Economics: Crisis
Management, 2011
London School of Hygiene and Tropical
Medicine
M.Sc. Public Health, 2012,
Thouron Scholar, 2011-2012
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2017
An opportunity to transform maternal
and pediatric surgical care delivery.
McKinsey and Company, New York NY
Summer Associate, Summer 2016
Collaborated with medical and brand
managers to develop the medical
affairs strategy and go-to-market plan
for a rare disease drug launch.
Designed and implemented analyses
including price factor, contract life
cycle, and therapeutic equivalence to
identify $80M in cost savings opportu-
nity in hospital supply chain and
pharmaceutical procurement for
a large health system.
The Children’s Hospital of Philadelphia,
Philadelphia, PA
Research Associate, 2015-present
Designed and implemented a study
to evaluate the cost-effectiveness of
treating pediatric trauma patients in
different clinical settings. Employed
geographical informational systems to
develop a network analysis of pediat-
ric trauma utilization. Conducted
analyses to evaluate the effectiveness
of various surgical ligation devices in
a porcine model.
10
Steven T. Cupps
Harvard College, Cambridge, MA
A.B., Cum Laude, Human Evolutionary Biology,
2009
An opportunity to join an innovative
team that is systemically transforming
healthcare services by building better
technology for providers, payers, or
consumers.
Welltok, Newport Beach, CA
Executive Intern to the CEO, Summer 2016
Led Strategic Planning process by
coordinating 16 senior executives to
develop an enterprise financing and
capital plan, inorganic and organic
growth plans for 6 business units, and
a go-to-market strategy. The plan was
presented to the Welltok Board and
is being implemented. Also provided
“Chief-of-Staff” type support to the
CEO including special projects: internal
investment process improvement, cli-
ent-facing white paper development,
“all-hands” material creation for 360+
employees, and investor pitch support.
Oliver Wyman, San Francisco, CA
Engagement Manager, 2015
Associate, 2013-2014
Senior Consultant, 2012-2013
Consultant, 2009-2012
Strategy consultant specialized in
the Health and Life Sciences Practice.
Executed 21 projects for 18 clients
across payers, providers, biopharma,
and health tech. Focused on fee-for-
value transformation, consumerism,
and the convergence of healthcare
with other industries. Spent 12 months
launching the Oliver Wyman Health
Innovation Center, a collaborative
group of senior leaders from across
healthcare with the mission of trans-
forming the sector.
Elizabeth L. Celata
The Wharton School, University of
Pennsylvania, Philadelphia, PA
B.S., Magna Cum Laude, Business and Public
Policy and Health Care Management, 2011
An opportunity to improve patient care
through developing and executing strat-
egies for biopharmaceutical companies.
Takeda Pharmaceutical Company,
Deerfield, IL
Commercial Leadership MBA Intern,
Summer 2016
Served as Strategy and Operations
intern to SVP of General Medicines
Business Unit, gaining broad exposure
across sales, marketing and managed
markets organizations. Created and
facilitated workshops for 70+ partici-
pants to help build understanding of
new working model. Revised quantita-
tive metrics and developed tracker to
track progress aligned to organiza-
tional goals. Analyzed current vendors
and identified opportunities for
30% reduction. Worked with 3 MBA
interns to define a suite of marketing
materials to improve managed
markets pull-through.
The Boston Consulting Group,
Philadelphia, PA
Consultant, 2013-2015
Associate, 2011-2013
Analyzed company and investor
projections to set 3-5 year commercial
strategy for Global Pharmaceutical
company. Identified growth opportu-
nities for mature brand through quali-
tative research and sales data analytics
and supported execution of recom-
mendations including content devel-
opment for sales meeting and creation
of executive scorecard. Worked with
client team to develop new operating
model for U.S. Oncology business to
address changing market.
Christine Casey
Duke University, Durham, NC
M.A., Spanish and Latin American Studies,
2010
An opportunity to serve health care
companies interested in strategic and
operational innovation.
McKinsey & Company, Palo Alto, CA
Summer Associate, Summer 2016
Advised Fortune 200 biopharmaceuti-
cal CEO on the integration strategy,
including salesforce redesign and
product positioning, for a newly-
acquired business unit. Conducted an
assessment of a niche hospital supply
market for a Fortune 500 medical
products company.
Avalere Health, Washington, DC
Senior Associate, 2013-2015
Assessed the impact of the Affordable
Care Act on business strategy for phar-
maceutical manufacturers and provid-
ers. Conducted analysis on data about
prescription drug access and sources of
insurance coverage to inform client
state and federal advocacy strategy.
Generated risk and opportunity
assessments to evaluate coverage
and reimbursement of existing and
new-to-market drugs.
Advisory Board Company,
Washington, DC
Dedicated Advisor, 2011-2013
Research Analyst, 2010-2011
Led implementation of competitive
intelligence software for 15 health
systems. Collaborated with hospital ex-
ecutives to leverage data for strategic
planning and physician outreach.
Secured contract renewals through de-
velopment of ROI case studies. Secured
$350K of new revenue in one quarter
as lead consultant on proof of concept
contracts. Won executive support by
identifying client needs and imple-
menting pilot projects through inten-
sive engagements. Conducted 1 to 6
month research studies to surface op-
portunities in hospital payment and
delivery reform.
11
Vikram A. Dashputre
University of North Carolina, Chapel Hill, NC
B.S.B.A., Highest Distinction, Business Adminis-
tration and Economics, 2010
An operational role with an organiza-
tion improving healthcare delivery.
DaVita HealthCare Partners, Denver, CO
Redwoods Summer Associate, Summer 2016
Developed business case for risk-based
relationships with partners managing
small populations. Proposed strategy
to manage risk internally, and recom-
mended specific payment structures
and partnership types.
Enhanced Equity Funds, New York, NY
Private Equity Associate, 2013-2015
Evaluated investment opportunities
at healthcare services private equity
firm with $600M under management.
Worked with portfolio companies
to coordinate due diligence, deal
execution and refinancing processes
related to add-on acquisitions.
Supported management teams in
budgeting, strategic planning and
capital structure decisions.
NewYork-Presbyterian Morgan Stanley
Children’s Hospital, New York, NY
Morgan Stanley Ambassador, 2012-2013
Selected by Morgan Stanley to spend
a year supporting strategic initiatives
at NewYork-Presbyterian Hospital.
Managed project to design a clinical
pathway for pediatric asthma.
Led committee to improve patient
throughput and created dashboards
monitoring hand-off issues, turn-
around time and best-practice
compliance.
Morgan Stanley, New York, NY
Healthcare Investment Banking Analyst,
2010-2012
Supported execution of M&A and capi-
tal-raising transactions for healthcare
sector clients, including Alkermes’ $1B
merger with EDT and Sigma-Aldrich’s
$350M acquisition of BioReliance.
Siddharth Damania
Stanford University, Stanford, CA
B.A., Economics, 2012
M.A., Public Policy, 2012
An opportunity to build new health
care businesses through an operational
or strategic role.
Medtronic, Minneapolis, MN
Business Development Summer Associate,
Summer 2016
Developed the product, technology,
and market strategy for a new con-
sumer disease management device,
representing a 4M U.S. patient oppor-
tunity. Designed novel business models
for nascent type II diabetes business,
developing partnerships with pharma
and technology companies and identi-
fying market expansion strategies for
existing portfolio.
Oliver Wyman, New York, NY
Associate, 2015
Senior Consultant, 2014
Consultant, 2012-2013
Managed teams to deliver fact-based
solutions for executives, with a focus
on health services. Key projects
included an enterprise redesign for a
top 10 healthcare system, the develop-
ment of a novel fraud detection
process for a federal agency (80x ROI),
and a due diligence of medical clinics
to inform a PE investment decision.
Recipient of Client Award, recognizing
project work with the greatest client
impact.
Spiritual Nutrients, Minneapolis, MN
Consultant, 2012-Present
Grew natural products family business
by 50% by developing customer acqui-
sition strategy and creating a suite of
online brand management products.
Created pitch decks to secure 25%
of new customer relationships and
first-ever exclusive contracts.
Alexander P.
D’Amato
Princeton University, Princeton, NJ
A.B., Magna Cum Laude, Sociology, 2009
An operational opportunity to improve
the managed care system through
increased efficiency and effectiveness
as reflected in patient cost, quality and
outcomes.
UnitedHealthcare, Minnetonka, MN
Strategic Initiatives Intern – Community
& State, Summer 2016
Various operational projects for
Medicaid state plan leadership.
Designed a holistic operating model
for members with commercial as well
as managed Medicaid coverage
(children with special needs) across
five plan functions. Developed
improved process and procedures
for state MMP reporting procedures.
Evolent Health, Arlington, VA
Director, 2013-2015
Associate Director, 2012-2013
Senior Analyst, 2011-2012
Worked with other founders as com-
pany’s fourth employee to establish
business plan, create financial models,
and review results with potential
customers and investors, which
culminated in $20M initial funding.
Developed several generations of new
products for firm. Ultimately oversaw
staff that built new business case
models and set pricing for new clients
resulting in $130M in revenue.
Dean & Company, Vienna, VA
Analyst, 2009-2011
Designed and created analytical model
to prioritize infrastructure investments
for a major wireline telecommunica-
tions provider in the high-speed
internet market.
12
Harris C. Drantch
Indiana University, Bloomington, IN
B.S., With Honors, Finance, 2010
An opportunity to make a significant
contribution to the growth and
development of an early stage
health care company.
New Capital Partners, Philadelphia, PA
CxO Associate – Medsurant Holdings,
Summer 2016
Worked as part of Medsurant’s senior
management team on a variety of
strategic projects including: identifying
opportunities to increase net revenue
per case, standardizing clinical
practices, reorganizing outside sales
processes and improving billing /
collections efficiency. Identified an
opportunity to increase net revenue
per case by ~13%, presented findings
to regional presidents and developed
a plan to implement related improve-
ments.
Wafra Partners, New York, NY
Assistant Vice President, 2013-2015
Associate, 2012-2013
Identified, evaluated, and executed
investments for a consolidation strat-
egy focused private / growth equity
firm (latest fund $300M). Monitored
existing portfolio company perfor-
mance through attending board meet-
ings and performing regular valuation
/ alternatives analyses. Worked with
existing portfolio companies on
executing strategic projects and
acquisitions.
Cain Brothers & Company,
New York, NY
Analyst – Mergers and Acquisitions,
2011-2012
Executed middle market leveraged
buyouts, private capital raises, and
strategic mergers and acquisitions
for a variety of health care services
companies.
Allison E. Dender
Washington University, St. Louis, MO
M.S. Finance, Knight Scholar, Beta Gama
Sigma, 2010
B.S.B.A., Magna Cum Laude, Finance and
International Business, 2010
An opportunity in private equity to
identify, build, and transform market-
leading healthcare companies.
Community Veterinary Partners
(Portfolio company of Cortec Group),
Philadelphia, PA
MBA Intern and Board Observer,
Summer 2016
Analyzed opportunities for opera-
tional improvement across 21 hospitals
for President and CFO. Motivated
practice managers to implement price
increases that add $500,000 of annual
revenue.
Sentinel Capital Partners, New York, NY
Private Equity Senior Associate, 2014-2015
Private Equity Associate, 2012-2014
Evaluated, executed, and monitored
investments for top quartile private
equity firm investing a $1.3B fund.
Managed Associates and third party
consultants to execute leveraged
buyouts and add-on acquisitions.
Board Observer of Hospice Advantage,
Corporate Visions, North American
Rescue, and Critical Solutions
International. Completed leveraged
buyout of Hospice Advantage, exe-
cuted buy and build investment thesis
by leading 13 acquisitions, and sold to
Hospice Compassus in three years.
Piper Jaffray, New York, NY
Investment Banking Analyst, 2010-2012
Advised on and executed middle
market leveraged buyouts, mergers
and acquisitions, public and private
capital raises, and competed for
prospective investment banking
mandates.
Timothy J. Daubert
Lafayette College, Easton, PA
A.B., Magna Cum Laude, Biochemistry, 2009
An opportunity to build and grow an
innovative early-stage digital health
company.
Nuna Health, San Francisco, CA
Strategy Intern, Summer 2016
Conducted market segmentation and
competitive landscape analysis for
a healthcare data science startup.
Worked with the CEO and senior lead-
ership to refine company pitch deck;
participated in Business Development
meetings with prospective clients; col-
laborated with Product Development
team on product strategy.
The Advisory Board Company,
Washington, DC
Director, 2014-2015
Associate Director, 2012-2014
Senior Business Analyst, 2011-2012
Managed Implementation and
Support teams for the Surgical
Profitability Business Intelligence pro-
gram, an operational efficiency and
cost containment technology serving
130+ hospitals and health systems na-
tionwide. Restructured business ana-
lyst teams into cross-functional model,
leading to 30% reduction in imple-
mentation timelines and 40% decrease
in support request completion time.
Founded Cost & Operations Innovation
Initiative and led 150-person depart-
ment in 2013 and 2014 innovation
campaigns.
Oracle Corporation, Philadelphia, PA
Senior Consultant 2010-2011
Staff Consultant 2009-2011
Established and maintained trusted
partnerships with pharmaceutical
clients as a dedicated resource for
designing over 20 clinical drug trial
management software implementa-
tions. Coordinated internal develop-
ment teams to ensure complete
programming and validation;
conducted in-depth user acceptance
testing to verify client deliverables.
13
Kevin T. Fennell
University of Michigan, Ann Arbor, MI
B.B.A., With High Distinction, Phi Beta Kappa,
Finance 2012
An opportunity to launch and imple-
ment new products, services and operat-
ing models that improve the efficiency,
affordability and quality of patient care.
Aledade, Bethesda, MD
Summer MBA Intern, Summer 2016
Oversaw development of pitch materi-
als for new business opportunities,
including new equity and debt financ-
ing, partnerships with 3 regional
commercial payers, and proposed
management contract for a physician-
led Accountable Care Organization
with over 40,000 covered lives.
Developed financial projection tool to
estimate impact of regulatory changes
(e.g., Merit-based Incentive Payment
System) and value-based care opportu-
nities (e.g., Medicare Shared Savings
Program) for new potential practices.
Strategy& (formerly Booz & Company),
Chicago, IL
Associate, 2014-2015
Consultant, 2012-2014
Strategy consultant for firm’s health-
care clients, including health systems
and health insurance companies.
Project work included customer
experience strategy, new product
development and channel strategy,
M&A integration, and operational
improvement. Project highlights: (1)
developed customer experience strat-
egy for regional health plan, identify-
ing >$200M in operating income
potential through improved efficiency
and growth in customer sales, (2) led
cost analysis and vendor capability
assessment for operational transfor-
mation at regional health plan,
resulting in $1B in organizational
investment for operations and
technology redesign.
Kenneth W. Ewell
Princeton University, Princeton, NJ
A.B., Economics, 2009
An opportunity to build and work
on effective teams within health care
services or devices, with responsibility
for both operations and strategy.
Medtronic, Minneapolis, MN
Product Strategy, Summer 2016
Identified and presented opportunity
to General Manager to enter new
$120M+ market with implantable
remote patient monitor; initiated
pilot study discussion with hospital,
recommended next steps. Analyzed
economic value case using payer data-
set; identified $12M in annual system
savings achievable within 5 years.
Sourced and conducted interviews
with 6 leading surgeons to understand
status quo and market needs; negoti-
ated, commissioned, and managed
qualitative market research study.
Received highest rating from manager.
Quvat Capital Partners, Singapore
and Jakarta, Indonesia
Junior Associate, 2014-2015
Senior Analyst, 2013-2014
Evaluated, managed, and exited
emerging markets investments for
$500M Indonesian private equity fund.
Led individuals and cross-cultural
teams in transactions in Indonesia,
Korea, and China. Initiated and led
training and mentorship program for
12+ junior analysts; named Head of
Training by CEO.
Princeton in Asia, Manila, Philippines
Nonprofit Fellow, 2011-2012
J.P. Morgan Securities, LLC
Analyst, Healthcare Investment Banking,
2009-2011
Executed debt, equity, and M&A trans-
actions, and competed for prospective
investment banking mandates on
three- to five-person teams.
Raul Estrada
ITESM, Monterrey, Mexico
B.Sc., Summa Cum Laude, Biotechnology
Engineering, 2011
An opportunity to develop and execute
innovative strategies for health services
or biotech companies.
DaVita Healthcare Partners, Denver, CO
Redwoods Summer Associate, Summer 2016
Developed a predictive model to iden-
tify key drivers of patient enrollment
for Paladina Health (direct primary
care) analyzing more than 30 variables
and 97% of covered lives. Identified
and prioritized 20 initiatives to
increase enrollment which became
the team’s strategic scorecard.
Bill & Melinda Gates Foundation,
Seattle, WA
Integrated Development Associate,
2014-2015
Strategy and project manager for
the Diagnostics team. Projects include
leading a team of two to assess the
viability of a US $500M multi-disease,
point-of-care diagnostic tool for com-
munity health centers in sub-Saharan
Africa, and acting as the project man-
ager for the Foundation’s Ebola 2014
outbreak diagnostics response team.
Bain & Company, Mexico City, Mexico
Senior Associate Consultant, 2014-2015
Associate Consultant, 2012-2014
Strategy consultant across sectors, with
clients in Pharmaceuticals, Financial
Services, CPG, and Industrial Goods
industries. Project experience includes
performing a commercial due
diligence on leading biosimilars
manufacturer, identifying regulatory
and competitive risks for existing
and pipeline products. Performance
trajectory assessed as “frequently
exceeding expectations.”
14
Jeffrey M. Fiore
Washington University in St. Louis
B.A., Honors, Economics, Psychology, 2010
An opportunity to work with a dynamic
healthcare company leveraging technol-
ogy to improve health care services.
Teladoc, Purchase, NY
Corporate Strategy and Product
Management Intern, Summer 2016
Led market research, partnership
strategy and product definition for
offering in $32B physical therapy
market from inception to initial
design. Analyzed health system
telehealth market and recommended
strategic position relative to electronic
health record vendors.
Ernst & Young Healthcare Advisory,
New York, NY
Senior Consultant, 2014-2015
Staff Consultant, 2013-2014
Advised health systems in revenue
cycle operations and IT optimization.
Projects included revenue cycle
modernization for Mayo Clinic and im-
plementation of a centralized Patient
Access unit for the University of
Virginia Health System. Co-led team
to improve offerings supporting
Epic Systems resulting in over $10M
of client contracts.
Epic Systems, Madison, WI
Application Manager, 2012-2013
Application Coordinator, 2010-012
Managed multi-million dollar
implementations of Epic’s revenue
cycle applications. Advised clients post-
implementation in system optimiza-
tion including a project at Froedtert
Health System resulting in perfor-
mance statistics in top 10% of
customers. Directed internal team in
preparing best-practice recommenda-
tions and setting direction for future
development.
Matthew R. Filer
The University of North Carolina,
Chapel Hill, NC
B.S., Business Administration 2009
Seeking investment opportunities
in growing, lower middle market
healthcare companies.
Ventus Health Investors,
Philadelphia, PA
Managing Partner, 2016-Present
Lead deal sourcing, investment
due diligence, fund operations and
investor relations for a small, private
investment fund.
Nautic Partners, Providence, RI
Healthcare Private Equity Associate,
2012-2015
Responsible for investment due
diligence, deal execution and portfolio
company strategy for a $3B middle
market private equity fund.
Investment experience across health-
care sectors, including post-acute care,
home care, behavioral health, urgent
care, disease management and
medical practice management.
Deloitte Consulting, Atlanta, GA
Consultant, 2011
Business Analyst, 2009-2011
Strategy consultant to Fortune 500
retail and consumer products compa-
nies. Led small teams of junior consul-
tants in delivering strategic planning,
organic growth strategy, new market
entry, and pricing strategy engage-
ments.
Gonzalo T. Ferrer
Texas Christian University, Fort Worth, TX
B.B.A., Summa Cum Laude, Finance, 2010
An opportunity to work in the health
care services space in a role that
combines strategy and operations.
Bain & Company, Dallas, TX
Summer Associate, Summer 2016
Worked on a digital transformation of
a large bank. My work focused on the
utilization of data for decision making
and program performance evaluation.
DaVita Healthcare Partners, Denver, CO
Manager – Special Projects, 2013-2015
Co-led team for a rapidly growing new
patient education program, utilizing
data to drive insights, identify oppor-
tunities, and execute improvements.
Managed data and analytics team and
a team of social workers.
VMG Health, Dallas, TX
Senior Analyst, 2010-2013
Led financial statement analysis and
due diligence for transaction-driven
equity pricing of privately owned
companies in various areas of the
health care services industry.
15
Julia S. Goldner
Brown University, Providence, RI
Sc.B., Magna Cum Laude, Biomedical
Engineering, 2011
A strategic or operational role within a
mission-driven organization focused on
delivering or supporting value-based,
innovative care.
Accolade, Plymouth Meeting, PA
Strategy / Operations Innovation Intern,
Summer 2016
Worked with Chief Strategy Officer
to develop internal perspectives on
pursuing the health system market
and on value-based reimbursement
dynamics. Worked with the VP of
Operations Innovation to complete in-
depth cost-of-service analysis to better
understand Health Assistants’ time and
productivity improvement opportuni-
ties. Conducted internal interviews to
identify operational considerations
and effort required to support a new
product launch.
Oliver Wyman, Health & Life Sciences,
New York, NY
Engagement Manager, 2015
Associate, 2014
Consultant / Senior Consultant, 2011-2013
Worked with health insurers and pro-
viders largely focused on transforming
toward value-based care. For a large
regional insurer, coordinated product
design and network contracting for
one Medicare Advantage and two
commercial individual products for
2015 launch. For a large regional
provider, developed 5-year financial
projection with client’s budgeting,
finance, and clinical integration teams
to demonstrate impacts of managing
population health. For various proj-
ects, deployed surveys, conducted ex-
pert/consumer interviews, facilitated
workshops, and led teams of 2-4
consultants to meet client needs.
Andrew Goberstein
Bentley College, Waltham, MA
B.S., Finance, 2009
An opportunity to build successful
healthcare businesses through a private
equity investing role.
Frazier Healthcare Partners, Seattle, WA
Summer Associate, Summer 2016
Evaluated middle-market, private
equity investment opportunities in the
healthcare sector. Executed platform
investment of a dermatology group.
Court Square Capital Partners,
New York, NY
Private Equity Associate, 2012-2015
Assessed investment opportunities,
performed financial and business due
diligence and assisted portfolio com-
pany managers for private equity firm
with over $6B in AUM. Completed two
portfolio company sales (Western
Dental and The Harvard Drug Group),
an add-on acquisition for The Harvard
Drug Group, and a dividend recapital-
ization for The Harvard Drug Group.
Worked with an operating partner to
develop an investment thesis in HCIT
by performing industry research, iden-
tifying attractive sub-segments of
HCIT, and identifying companies
within those sub-segments to invest.
J.P. Morgan Securities, New York, NY
Financial Sponsor Group Analyst, 2009-2012
Executed leveraged finance, M&A and
equity transaction on behalf of large-
cap and middle market private equity
clients. Provided secondary coverage
on Apollo, GTCR and BC Partners.
Transaction experience included
financing The Carlyle Group and
Hellman & Friedman’s leveraged
buyout of Pharmaceutical Product
Development, financing Veritas’
leveraged buyout of Truven Analytics,
and underwriting The Carlyle
Groups’ IPO.
Prerak Garg
The Young India Fellowship, New Delhi, India
Postgraduate Fellowship in Liberal Studies, 2011
Indian Institute of Technology, Kharagpur, India
B.Tech., With Honors, Chemical Engineering,
2010
An opportunity to operate and invest
in successful healthcare businesses
through private equity or venture
capital in Asia.
McKinsey & Company, Summit, NJ
Summer Associate, Summer 2016
Led 6 performance transformation
projects including portfolio and prod-
uct complexity reduction, network
consolidation, material cost reduction,
and operations restructuring with
$325M NPV for a $70B sales global
healthcare firm.
Cipla Ltd, Mumbai, India
Head, Global Supply Chain Transformation
Office, 2014-2015
Manager, Global Supply Chain
Transformation Office, 2012-2014
Led 20+ projects across 5 departments
in order to arrest decline in firm’s
growth rate. Increased revenue
growth 2.5x for $800M export business
by setting up 35 cross-functional teams
and improving on-time delivery 4x
for 23,000 SKUs in 160 countries.
Introduced best practices in procure-
ment, saving $12M annually. Spear-
headed post-merger turnaround of
$103M acquisition in Africa, achieving
$5M in savings and 50% revenue
growth in 1 year. 1 of 2 employees
recognized by CEO for role in transfor-
mation.
Office of Naveen Jindal, Member
of Parliament, New Delhi, India
Consultant Intern, 2011-2012
Conceptualized and implemented
development initiatives worth $10M
in 1,100 villages in rural India.
Indian Oil Corporation Ltd,
Barauni, India
Officer, 2010-2011
Advised Deputy General Manager
of the largest refinery in the region
(6 MMTPA) on re-modeling various
units and increasing efficiency.
16
Jason Han
University of Pennsylvania, Philadelphia, PA
B.A., Chemistry/B.S., Finance, Life Sciences
and Management Program, 2010
A growth oriented operational role
that combines my provider and analytic
experiences to make an impact in
patient care.
Clover Health, Jersey City, NJ
New Markets Intern, Summer 2016
Developed analytics dashboards to
enable network management team
to drive profitability in local markets.
Built operations workflow tool to sup-
port physician contracting, credential-
ing, and network expansion.
New York Presbyterian, New York, NY
Manager, 2012-2015
Led the project management / consult-
ing team of 9 within the clinical
analytics department. Partnered and
engaged with front-end clinicians in
the design and implementation of
Health IT solutions. Hosted the first
Hackathon at NYP to identify opportu-
nities to reduce patient length of stay
at the hospital.
Accenture, New York, NY
Analyst, 2010-2012
Published “Thought Leadership:
Building on Meaningful Use: Three
Opportunities for High Performance.”
Managed collaborative work team to
build system-wide metrics scorecard
consisting of 30 members, including
CMIOs, service line directors, and
clinical leadership across 12 facilities
for a large catholic healthcare system.
Glen Elizabeth
Graves
Northwestern University, Evanston, IL
B.S., Social Policy, Economics, 2010
An opportunity to work with dynamic
teams at the intersection of health care
strategy and policy.
McKinsey & Company, Denver, CO
Summer Associate, Summer 2016
Worked on supply chain initiative for
national hospital system. Worked with
client leadership to evaluate existing
best practices and develop standard-
ized monthly performance metrics and
reporting processes.
DaVita Healthcare Partners, Denver, CO
Manager & Senior Analyst, Special Projects,
2013-2015
Senior Analyst, 2012-2013
Redwoods Analyst, 2010-2012
Partnered with integrated care leader-
ship to develop innovative clinical ser-
vice offerings with external partners,
including an Accountable Care
Organization and an insurance
company. Oversaw field operations,
external partnerships, and growth
strategy in nine states for Kidney
Smart, DaVita’s kidney disease educa-
tion program. Set agenda and drove
strategic operations and policy
solutions as part of a multi-team
healthcare exchange working group.
Developed and owned healthcare
exchange five-year financial model.
Managed program analytics,
forecasting, and reporting team.
Julie S. Goodman
Cornell University, Ithaca, NY
B.S., Operations Research and Engineering,
2011
An opportunity to transform care deliv-
ery through an operational or strategic
role at a health care technology com-
pany.
athenahealth, Watertown, MA
Clinical Operations MBA Intern,
Summer 2016
Collaborated with providers and ad-
ministrative staff to reduce the time
providers spend documenting in
athenaClinicals outside of encounters.
Utilized analytics tools to identify and
assess 12 opportunities to shift the
co-sourcing model so that athena can
take on a greater breadth and depth
of client work. Presented recommen-
dations on process redesign and
best practice initiatives to CEO and
executive leadership.
Deloitte Consulting, LLP, Boston, MA
Consultant, 2013-2015
Business Technology Analyst, 2011-2013
Primarily served large health insurance
companies, focusing on improving
operational efficiencies through tech-
nology-enabled solutions. Led deliver-
ables, managed client expectations,
and cultivated junior practitioners as
pivotal member of service delivery
team. Collaborated with IT and
business teams to drive prioritization,
analysis and resolution of operational
challenges. Managed, initiated, and
implemented new processes and
technologies to increase operational
efficiencies.
17
Yang Hu
University of Pennsylvania, Philadelphia, PA
B.A., Summa Cum Laude, Economics, 2012
An opportunity to improve healthcare
access for developing countries or rural
communities through technology and
strategy.
Clinton Health Access Initiative,
Phnom Penh, Cambodia
Volunteer, Summer 2016
Conducted an assessment of financial
management systems at the National
Malaria Center (CNM), Ministry of
Health in Cambodia with an objective
to increase spending of $18M interna-
tional grants. Developed a Grant
Management Manual to formalize the
policy and procedures for spending
and managing grants awarded to
CNM. Developed a new Cambodia
national forecasting tool for malaria
drugs and diagnostics.
Deloitte Consulting, New York, NY
Consultant, 2014-2015
Business Analyst, 2012-2014
Strategy and operations consultant for
clients across pharmaceutical, biotech-
nology, health plans, providers, and
health care technology sectors. Sample
projects include 1) developing cost
reduction and process improvement
initiatives resulting in over $1M in
savings for a regional hospital system;
2) team lead for the design and imple-
mentation of Connecticut’s Health
Insurance Exchange mandated by
Obama Care; 3) creating a knowledge
management tool for a global
biotechnology client to cover over
100 molecular, imaging and clinical
trial databases.
Brandon Holler
Northwestern University, Evanston, IL
B.S, Industrial Engineering and Economics,
2008
An opportunity to work with a dynamic
mission driven team to deliver rapid
growth at a health technology company.
Quartet Health, New York, NY
Business Development MBA Intern, Summer
2016
Developed an economic model to
quantify value proposition to hospitals
and health systems operating in
various fee-for-service reimbursement
environments and those transitioning
to value-based reimbursement envi-
ronments. Supported sales campaigns
and codified a customer journey
playbook including tool templates,
business guidelines and key
milestones. Led scan of partnership
landscape to augment capabilities.
HealthScape Advisors, Chicago, IL
Manager, 2014-2015
Senior Consultant, 2011-2014
Strategy and operations consultant
for health plan clients and risk-bearing
provider systems. Advised clients
through pre and post-ACA implemen-
tation challenges including risk adjust-
ment impacts and exchange strategy.
Led health plan behavioral health
strategy transition over 24 months
through assessment, sourcing,
contracting and implementation
securing over $90M in savings.
FTI Healthcare, Chicago, IL
Senior Consultant, 2011-2011
Consultant, 2008-2010
Performance improvement consultant
for hospital and health system clients
including revenue cycle improvement,
service line analysis, supply chain
management, and labor productivity.
Led analytical development of new
Clinical Effectiveness service offering
using comparative statistical analysis
to identify physician variation and
track financial and clinical impact
of process redesign.
Nathalie J. Herman
Wellesley College, Wellesley, MA
B.A., Magna Cum Laude, Economics and
French, 2011
An opportunity to work on a dynamic
team within health care consulting,
with focus on biotech and diagnostics.
LEK Consulting, Los Angeles, CA
Summer Consultant, Summer 2016
Collaborated with cancer diagnostic
company to develop short and long-
term biopharmaceutical partnership
strategy; identified and prioritized top
biopharmaceuticals for $100M+ collab-
oration. Performed due diligence on
$30M revenue regulatory lab testing
company; conducted 15-20 key opin-
ion leader and customer interviews;
identified and quantified five revenue
and three cost-based synergies and
developed purchase recommendation
to support acquisition.
The Amundsen Group, an IMS Health
Company, San Francisco, CA &
Boston, MA
Consultant, 2013-2015
Associate Consultant, 2011-2013
Collaborated with top 10 large phar-
maceutical companies to develop and
implement revenue maximizing strate-
gies. Designed physician and payer
market research surveys and interview
guides to understand physician
prescribing and payer coverage for
pre-launch high cost specialty drugs;
conducted physician and payer inter-
views; developed optimal launch
strategies based on healthcare market
landscape. Delivered client site presen-
tations outlining optimal launch strat-
egies, contracting recommendations
between the drug manufacturer and
payers, and patent loss trajectories.
18
Amit Jayakar
Georgetown University, Washington, DC
B.A., Economics and Mathematics, 2009
An opportunity to combine my
experience in technology and finance
to improve healthcare delivery models.
Wellthie, New York, NY
MBA Business Development Intern,
Summer 2016
Managed fundraising process for
Wellthie’s first institutional investment
round, and created sales infrastructure
for prospects with our new core prod-
uct. Developed resource requirements
to navigate funding strategy and
communication to potential investors.
Successfully closed on the initial
$500,000 and signed the first
enterprise broker customer.
Miami Children’s Hospital, Miami, FL
Business Specialist, 2014-2015
Developed pilot model for a $50M
service line to assess the financial
feasibility of value-based health
care in a regional pediatric hospital.
Responsibilities included negotiating
a $5M bundled payment surgery
contract with multiple commercial
insurance payers, and benchmarking
the base-line economics of the hospital
and insurance carriers.
Vista Equity Partners, San Francisco, CA
Senior Analyst, 2011-2014
Led transaction diligence efforts for
the evaluation and execution of
eight software company acquisitions
accounting for roughly $2B across
multiple verticals including healthcare,
energy, and transportation.
Shubhra Jain, M.D.
Stanford University, Stanford, California
Masters in Mechanical Engineering, 2012
Kasturba Medical College, Manipal, India
Bachelor of Medicine & Bachelor of Surgery,
2010
An opportunity to use my clinical,
technical and business skills to build in-
novative health care companies.
Bank of America, New York, NY
Summer Associate, Healthcare Investment
Banking, Summer 2016
Analyzed credit risk considerations
for a $1B Term Loan refinancing for
a $30B Healthcare Services Client.
Identified potential bolt on M&A tar-
gets and executed due diligence for a
$655M sponsor acquisition financing
of a medical device company.
Red and Blue Ventures, Philadelphia, PA
Summer Associate, Venture Capital,
Summer 2016
Conducted due diligence on 15
Healthcare IT deals. Sourced 50 deals
over 5 weeks by leveraging personal
connections with entrepreneur
forums.
Parkland Center for Clinical Innovation,
Dallas, TX
Product Manager, 2014-2015
Led conceptualization and develop-
ment of clinical prediction and
surveillance software for U.S. hospitals
and health systems including a $2.3M
IT solution which reduced mortality by
17% and enhanced treatment compli-
ance by 100% at a 1000 bed hospital.
Independent Consultant, Sunnyvale, CA
Independent Consultant, 2011-2014
Developed go to market strategies,
competitive analysis, growth prioritiza-
tion, resource forecasts and strategic
plans for Fortune 500 Clients and
startups.
Erica A. Jain
Duke University, Durham, NC
B.A. Health Disparities and Infectious Diseases,
2011
Opportunity to improve healthcare
access and delivery through innovative
care models and technology.
Healthie, New York, NY
CEO & Co-Founder, 2016
Healthie is a practice management
solution for nutrition professionals.
Providing an all-in-one solution for
scheduling, billing, charting, HIPAA-
compliant telehealth, and patient
communication. Nutritionists practice
more efficiently with improved client
outcomes. Healthie graduated from
Techstars NYC.
Boston Consulting Group, Dallas, TX
Management Consultant, 2011-2015
Due diligence for $22B Private Equity
Fund. Cost/profitability drivers, projec-
tions, 10-year hospital growth strategy/
governance design for top Uni ver sity
Medical Center. Trans formed Customer
Service design for Nationwide
Pharmacy for 2% increased revenue.
Cost reduction/strategic redesign for
Multinational Pharmaceutical Company
with a $1.6B impact on a prestigious
project (Tel Aviv/ Paris).
Clinton Health Access Initiative,
East Africa/USA
Program Analyst, New Initiatives –
Nutrition Program, 2013
Strategic team to combat malnutrition
for 26M infants in Ethiopia, Rwanda,
Kenya, Uganda. Economic feasibility,
strategy to generate donors and pri-
vate investors. Designed multinational
distribution system for baby food to
reach ‘the last mile,’ financial models
for the dairy and sugar industries.
Structured subsidy program to ensure
affordability by leveraging Rwanda’s
Ubudehe socioeconomic system and
The World Food Program adopted by
Ministries of Health and Agriculture.
Multiple Research and Publications
19
Matthew L. Katz
Wesleyan University, Middletown, CT
B.A., Honors, Economics & Government, 2011
An opportunity to lead strategic and
operational improvements to value-
based care arrangements.
Cigna, Philadelphia, PA
Value-Based Reimbursement Summer
Associate, Summer 2016
Designed and executed comprehensive
study of Cigna’s ACO support model.
Identified key value drivers from pro-
vider perspective. Research included
over 40 internal interviews, 10 external
interviews with ACO provider leaders,
and extensive analysis of national sur-
vey data. Presented final report and
strategic implications to a variety of
company leaders including the CMO
and multiple VPs.
Blue Shield of California,
El Dorado Hills, CA
Intermediate Configuration Analyst,
2014-2015
Associate Configuration Analyst, 2012-2014
Performed data analysis, solution engi-
neering, and testing for suite of insur-
ance software. Ensured new systems
supported business processes by
collaborating closely across internal
teams. As member of newly formed
internal testing team, designed and
implemented workflows and standard
operating procedures. Headed testing
of new software extension, identifying
three critical design flaws and
directing troubleshooting to meet
go-live date on time.
Operations Management Trainee,
2011-2012
Completed competitive rotational
program across Installation &
Membership, Customer Service, and
Claims departments. Conducted three
process improvement projects as
well as executed hands-on claims
processing and customer service.
Kunal Kandimalla
University of Pennsylvania, Philadelphia, PA
B.A., Cum Laude, Economics, 2010
An investment or operational opportu-
nity focused on building successful
companies in the life sciences and
adjacent sectors.
Novartis, Basel, Switzerland
MBA Intern, Corporate Strategy,
Summer 2016
Assisted with company-wide 5-year
strategic planning process for
Executive Team offsite. Helped with
operational framework for novel
managed care business focused on
using digital health technologies to
manage enrollees. Conducted compet-
itor benchmarking and drafted memo
for CEO on competitor digital health
strategies.
Agios Pharmaceuticals, Cambridge, MA
Manager, Business Development &
Operations, 2014-2015
Analyst, Business Development &
Operations, 2014
Assessed, presented and offered deal
support on early-stage in-license op-
portunities. Conducted financial, com-
mercial and scientific due diligence on
existing and new development pro-
grams. Assisted in corporate develop-
ment initiatives requested by Executive
Team and BOD, including drafting
buy-side business development strat-
egy, creating franchise co-promotion
models and evaluating ex-U.S. partner-
ing options for pipeline drug.
Putnam Associates, Boston, MA
Consultant, 2014
Analyst, Associate & Senior Associate,
2010-2013
Led teams in advising top 10 pharma-
ceutical companies on 25+ projects,
including revenue forecasting, market
and opportunity analysis, brand posi-
tioning and growth strategy, pricing
and market access strategy, clinical de-
velopment strategy, patent loss brand
retention and sales force optimization.
W. Tyler Jorgensen
Yale University, New Haven, CT
B.S. Applied Mathematics, 2010
An opportunity to improve patient
outcomes through technology, strategy,
and operations.
Medtronic, Santa Rosa, CA
Leadership Development Rotational Program
Summer Associate, Summer 2016
Worked on contracting strategy and
engaging a new customer segment in
the aortic business.
Picwell, Philadelphia, PA
Senior Data Scientist, 2013-2015
Developed health plan recommenda-
tion system, first for Medicare and
later for commercial insurance plans.
Products were deployed with a large
benefits manager and a large health
insurer.
Anapsis, San Francisco, CA
Cofounder, 2013
Gained acceptance to Rock Health
accelerator. Developed a web-based
platform through which analysts and
data scientists could share, collaborate
on, and run analytical code to
make their work more accessible,
transparent, and repeatable.
ZS Associates
Business Analytics Associate, 2010-2012
Developed the sales force strategy for
a biotech client to launch a prospec-
tive $10B peak revenue brand. Led the
analytics on an internal research proj-
ect to develop statistical models that
provide individualized promotional
messages. The models were later incor-
porated into a product deployed at
two pharmaceutical companies.
20
Susan J. Kim
University of Maryland, College Park, MD
B.S., Information Systems & Marketing, B.A.,
Psychology, 2011
An opportunity to combine my technical
and business background toward
advocating value-based care with a
focus on population health to reduce
costs, increase access and improve
quality of healthcare.
Collaborative Health Systems
(Universal American), White Plains, NY
MBA Strategy Intern, Summer 2016
Initiated development of a customized
care management and population
health dashboard prototype alongside
a clinical team in integrating disparate
data sources to provide a predictive
analytics tool to monitor beneficiary
health across 22 MSSP and Next
Generation ACOs. Conducted market
research to assess regional ACO
and primary care physician group
landscapes and trends within the U.S.
Deloitte Consulting, Arlington, VA
Senior Consultant, 2015
Consultant, 2013-2014
Business Technology Analyst, 2011-2012
Served healthcare and emerging
markets clients within the federal
government on systems integration
and adoption of new technologies.
Examples include a yearlong modern-
ization application release serving
9M+ U.S. citizens/nationals across 250+
global consulates and an innovative
data analytics visualization solution to
enhance communication and analysis
across multiple domains. Analyzed
statistical and historical trends to drive
client decision making in conjunction
with leading writing efforts on multi-
ple contracts and recompetes.
Melanie W. Kier
Yale University, New Haven, CT
B.A., Cum Laude, Economics, 2010
University of Pennsylvania School of Medicine,
Philadelphia, PA
M.D. Candidate, 2017
An opportunity to combine my clinical
and business experiences to improve
health care delivery.
CytomX Therapeutics Inc.,
San Francisco, CA
Clinical Development Intern, Summer 2016
Intern to Chief Medical Officer at a
biopharmaceutical company focused
on oncology immunotherapies utiliz-
ing its novel class of antibody thera-
peutics. Wrote the clinical portion of
the Investigational New Drug applica-
tion submitted to the FDA and wrote
portions of the phase 1 study protocol.
Created case report forms and ensured
data collection documents complied
with the protocol and met the needs
of the biostatistician. Reviewed
clinical site involvement, international
regulatory issues, commercial and
shipping requirements, and intellec-
tual property.
Memorial Sloan Kettering Cancer Center,
New York, NY
Research Study Assistant, 2011-2012
Research Study Assistant in Phase II
and Phase III breast cancer therapeutic
clinical trials sponsored by the National
Cancer Institute. Ensured all study com-
ponents and quality checks were met
for over 300 patients, i.e. completing
data entry, organizing patient’s clinic
schedules and tests, preparing for
inspection reviews, conducting radiol-
ogy review and collecting outcomes,
completing regulatory documents,
and submitting documents to the IRB.
Goldman Sachs, New York, NY
Summer Analyst, Summer 2009
Completed projects driven by
institutional and hedge fund clients,
who generated a variety of requests,
such as market updates and stock
analysis. Presented market projections
and collaborated with the research
team to formulate sales pitches.
Culminated in a full-time offer.
Jenna E. Kerner
Cornell University, Ithaca, NY
B.A., Summa Cum Laude, Neurobiology
and Behavior, B.A., Economics, 2011
An opportunity to combine my passion
for experience design and healthcare to
create products at an early stage digital
health company.
Doximity, San Francisco, CA
Product Management Intern, Summer 2016
Launched new feature for web prod-
uct to improve customer engagement.
Conducted in-depth user interviews to
understand customer needs, and ana-
lyzed existing data using SQL to build
case for launch. Conducted research
for new product, and devised strategy
for rollout.
Lumo Bodytech, Palo Alto, CA
Product Management Intern, Summer 2015
Translated user interview findings
into tactical software and hardware
changes, and coordinated with design-
ers and engineers to implement priori-
tized changes for next 24,000 units.
Built company-wide dynamic product
roadmap, which became guiding
document for Board of Directors and
company leadership. Implemented
first-time analytics for iOS and
Android, and developed process
for monthly measurement.
Deloitte Consulting, New York, NY
Consultant, 2013-2015
Business Analyst, 2011-2013
Focused on customer engagement
within life sciences industry. Project
work includes creating a diabetes
wellness program, customer experi-
ence innovation in oncology, process
redesign for R&D shift toward
precision medicine and information
management strategy for bioinformat-
ics department.
21
Andrea E. Klestadt
Yale University, New Haven, CT
B.A., Magna Cum Laude, with Honors in
Cognitive Science, 2011
An opportunity to improve health
outcomes and access to care through
technological or clinical innovation.
Quartet, New York, NY
Operations Intern, Summer 2016
Identified range of metrics to quantify
behavioral health provider engage-
ment and inform incentive contracts;
produced dynamic Excel tool to
consolidate these metrics and enable
field representatives to diagnose and
address engagement issues. Recom-
mended improvements to operational
processes, marketing, and product to
increase behavioral health provider
engagement with Quartet based on
field research and quantitative analy-
sis. Recruited passionate patient advo-
cates for Quartet through developing
and executing social media campaign.
ZS Associates, New York, NY
Business Associate Consultant, 2014-2015
Business Associate, 2011-2013
Sales and marketing strategy consul-
tant for multinational pharmaceutical
and biotech companies. Shaped the
U.S. and global launch strategies of 9
different products through a combina-
tion of quantitative analyses and qual-
itative market research interviews with
over 200 healthcare stakeholders.
Developed forecast models for pipe-
line and established drugs. Managed
cross-office consulting teams to
optimize clients’ sales force structure,
deployment and targeting. Handled
client communications, led presenta-
tions and directed workshops.
Michael P. Klein
Pomona College, Claremont, CA
B.A., Molecular Biology, 2010
David Geffen School of Medicine at UCLA,
Los Angeles, CA
M.D. Candidate, 2018
An opportunity to advise and build
companies at the crossroads between
healthcare, information technology
and finance.
Goldman Sachs, San Francisco, CA
Summer Associate, Investment Banking,
Summer 2016
Conducted financial analyses, due
diligence and M&A-focused materials
development across 5 clients in the
healthcare and technology industries.
Identified precedent financing
arrangements, modeled pro forma
leverage scenarios and detailed histori-
cal peer expense trends for CFO and
board of $2B company. Performed
diabetes devices market review and
strategic assessment of 25 potential
acquisition targets.
UCLA Health, Los Angeles, CA
Innovation Intern, Summer 2013
Co-authored interview-based “Patient
Voice” research framework published
in academic literature, presented to
health system executive team and
utilized in UCLA Health’s surgical
home and recurring innovation
competitions.
Deloitte Consulting, Los Angeles, CA
Business Analyst, 2010-2012
Worked on 9 team engagements with
focus on health system performance
improvement and health care informa-
tion technology. Created industry-
specific surgical services analyses to
identify $25M of annual savings for
10-hospital system. Supported
$300M-$1B EHR selection processes
and implementation planning, work-
ing closely with client IT leadership,
for 3 west coast health systems.
Jotham H. Klein
University of Pennsylvania, Philadelphia, PA
B.S., Magna Cum Laude, Economics, 2010
An opportunity to identify, build and
impact healthcare companies through
an equity investment role.
Fred Alger, New York, NY
Research Associate, Summer 2016
Evaluated public equity securities at
growth-oriented, $20B mutual fund.
Conducted fundamental research
including analysis of value drivers and
unit economics, construction of finan-
cial models, meetings with manage-
ment teams, interviews with customers
and suppliers, site visits, and industry
benchmarking. Earned multimillion
dollar capital allocation.
Apax Partners, New York, NY
Private Equity Associate, 2013-2015
Evaluated investment opportunities
in healthcare sector for $8B leveraged
buyout fund; involved in every aspect
of diligence process, including industry
analysis, business quality, synergy
potential, and financial assessment.
Constructed financial models, led ex-
ternal consultants, identified potential
cost savings, assisted management
teams. Board observer to portfolio
companies. Executed acquisitions of
One Call ($3.2B) and Genex ($460M).
Berenson & Co., New York, NY
Investment Banking Analyst, 2010-2013
Advised clients on middle market
leveraged buyouts, public and private
capital raises, and competed for
prospective investment banking man-
dates on three to five-person teams.
22
Craig Limoli
Princeton University, Princeton, NJ
A.B., Economics, 2012
Opportunities for my startup, WellSheet,
which uses analytics to surface key
information for complex patients
in an intuitive format.
WellSheet, New York, NY
Co-founder and CEO, 2015-Present
Founded WellSheet while at Wharton.
Recruited talent from clinical, technical
and design backgrounds to build out
the team. Earned over $30,000 in
grant funding from multiple sources,
including a federal grant. Oversaw the
team building a product that has
attracted interest from executives of
multiple major health systems, and
won recognition from the Office of
the National Coordinator as one of
the top innovations for improving the
provider experience. Launched 2 pilots
and a distribution partnership with
established digital health company.
International Business Machines,
Armonk, NY
Strategy Consultant, 2012-2014
Senior Strategy Consultant, 2014-2015
Performed high-profile business analy-
sis for executives at IBM headquarters
as internal consultant for IBM
Corporate Strategy to segment and
evaluate the consulting business unit.
Managed 8 person team performing
an assessment of a network of mental
health providers across a set of clinical,
business, and technology parameters.
Led large, multifunctional team, coor-
dinating with healthcare providers,
IBM experts, and client clinical team to
implement Electronic Medical Record
integration.
Elaine Le
Shanghai International Studies University,
China
B.S., Business Economics, 2010
A strategic or investment role with a
company across multiple health care
segments.
Warburg Pincus LLP, Shanghai, China
Summer Vice President, Health Care Team,
Summer 2016
Evaluated 14 public companies across
pharma, biotech, device and service
sectors, identified two investment
targets and initiated discussion.
Completed independent industry
analysis and made investment recom-
mendation for aesthetic medical
industry.
Cathay Capital Private Equity,
Shanghai, China
Associate, 2013-2015
Analyzed 30+ opportunities in China
and Europe, 80% in healthcare
industry. Assisted deal sourcing, led
transaction execution, drove cross-bor-
der value creation, and successfully
closed five investments with
aggregated deal size of $145M.
TE Connectivity, Shanghai, China
M&A Senior Analyst, 2012-2013
Drove the investment process for a
take-over acquisition that bridged a
major product gap. Developed a $30M
growth plan for Medical business unit
by analyzing market and competitive
dynamics, prioritized growth opportu-
nities and created implementation
plan.
A.T. Kearney Management Consulting,
Shanghai, China
Business Analyst, 2010-2011
Top performer within rank. Advised
financial investor clients on commer-
cial due diligence on retail chains and
telecom devices to evaluate market
potential and risk. Advised clients
develop new product strategy, supply
chain optimization and operation
efficiency improvement.
Aaron D. Kornetzke
The University of Wisconsin, Madison, WI
B.B.A., Finance, 2011
A business development or strategic
role at a company within the healthcare
technology space.
Doximity, San Francisco, CA
Business Development Intern, Summer 2016
Sourced and developed partnerships
in the medical application space and
managed Doximity’s API partnership
program. Assessed the company’s top
business development opportunities
and designed a framework through
which future growth opportunities
can be evaluated.
Procter & Gamble, Cincinnati, OH
Financial Analyst – Corporate Strategy,
2013-2015
Financial Analyst – Global Business Services,
2011-2013
Conducted various industry and
competitive analyses for senior man-
agement, including the CEO, CFO and
Board of Directors. Led a cross-func-
tional team through negotiations with
3 IT partners, resulting in the establish-
ment of a new IT infrastructure and
service partnership, valued at $75M+
over 5 years.
23
Matthew G.
McLaughlin
matthew.mclaughlin.wg17@
wharton.upenn.edu
Stanford University, Palo Alto, CA
B.A., Political Science, 2008
An opportunity to build a company that
empowers consumers to make more
informed decisions about their health.
Lazard, Los Angeles, CA
MBA Associate, Summer 2016
Co-developed marketing materials for
the divestiture of a ~$200M revenue
division of a space technology busi-
ness. Managed the sell-side diligence
process for a regional ethnic food
manufacturer (TEV ~$300M).
Kingfish Group, Foster City, CA
Principal, 2013–2015
Built the company’s healthcare
independent sponsor capabilities by
developing relationships with ~180
high-profile healthcare executives.
Generated 68 actionable investment
opportunities, 6 of which were propri-
etary. Collaborated with sponsors on
an $80M investment in a psychological
services provider.
Oliver Wyman, San Francisco, CA
Senior Consultant, 2012-2013
Consultant, 2010-2012
Advised global and U.S. clients on
a range of operational initiatives.
Notably, for a major U.S. residential
supply manufacturer, evaluated
~$96M in finished goods inventory
and developed recommendations
to reduce inventory by ~$22M.
Stanford Student Enterprises,
Stanford, CA
CEO, 2008-2010
Managed a ~$1.8M revenue business
with 50+ employees. Launched SSE
Labs (now StartX) — a seed accelerator
supporting student entrepreneurs.
Since its inception, the program has
graduated 100+ companies, which
have raised over $400M in funding.
Eriko Matsumoto
Keio University, Tokyo, Japan
B.A., Business and Commerce, 2007
A project management opportunity to
invest in health systems and create
health system models to improve
quality and cost effective management.
UAB Health System, Birmingham, AL
Administrative Fellow, Summer 2016
Created a strategic plan and analyzed
effectiveness of Access Center
to improve room utilization for
Neurology clinic and patients’
accessibility. Attended leadership
meetings to propose ideas on room
for improvement.
MC Healthcare, Inc., Tokyo, Japan
Senior Manager, Sales and Marketing
Department, 2012-2015
Unit Manager, Pharmaceutical Products Unit,
2011-2012
Led 6 sales people and responsible for
total sales activities to implement
supply chain management. Achieved
a large-scale order intake in 2013 of
$15 million of medical supplies for a
flagship hospital. Led Pharmaceutical
Products Committee for GPO;
Succeeded in negotiation with drug
manufacturers and reshaped previous
business model into new business
model first time ever in Japan.
Mitsubishi Corporation, Tokyo, Japan
Consultant/Sub-Project Manager, Healthcare
Business Department, 2007-Present
Led proposal-based hospital construc-
tion, maintenance and management
projects. Won a PFI tender for Kyoto
City Hospital ($0.9B in total, 18-year
contract); Pioneered a plan for cost
benchmarking for medical supplies
and pharmaceuticals procurement that
achieved a cost reduction of 5% in the
very first year of its implementation.
Ravi A. Mahadevia
Northwestern University, Evanston, IL
B.A., Psychology, 2008
An opportunity to build leading health
care services companies through
management or investment.
Somnium Sleep Solutions, New York, NY
Founder & CEO, 2012-Present
Developed unique sleep center
management contract business model,
researching market interest and opera-
tional feasibility across the country to
establish Somnium and open diagnos-
tic sleep centers to treat sleep apnea
by partnering with physician-owned
surgical hospitals. Led set-up of all
sleep centers by managing every part
of the process: hiring employees,
training staff, integrating sleep center
within the hospital, accounting, and
obtaining insurance contracts,
resulting in four centers that generate
over $1.5M in revenue annually.
Lincoln International, Chicago, IL
M&A Healthcare Investment Banking
Analyst, 2010-2012
Conducted due diligence, drafted deal
process materials, ran LBO and DCF
valuations, and completed other M&A
activities, resulting in seven closed
transactions that totaled over $750M
in valuations over two years.
Deloitte Consulting, Chicago, IL
Strategy & Operations Business Analyst /
Consultant, 2008-2010
Consultant in the health care services
and insurance sectors. Project exam-
ples include creating a new channel
strategy for a payer’s exclusive / inde-
pendent agent force and implement-
ing cost reduction strategies for a
large health care services business.
24
Ryan J. Mullaney
Boston College, Chestnut Hill, MA
B.S., Cum Laude, Finance, 2011
An opportunity to build, and invest
in, businesses focused on developing
curative therapies for rare diseases.
InTandem Capital Partners,
New York, NY
Summer Investment Professional,
Summer 2016
Worked directly with Managing
Partner and InTandem team in fund-
raising efforts by crafting LP presenta-
tions, attending LP meetings, and in
fulfilling LP requests. Supported live
transactional efforts in health care
services vertical by managing due-
diligence processes, building compre-
hensive financial model and valuation
materials, and working with lender
partners.
Riverside Partners, Boston, MA
Private Equity Associate, 2013-2015
Analyzed 30+ investment opportuni-
ties in healthcare and technology sec-
tors. Managed transaction execution
process including financial and opera-
tional due diligence, market and in-
dustry analyses, valuation and returns
analyses, and deal structuring and
legal documents. Closed two add-on
investments with aggregate deal size
of $35M. Successfully exited invest-
ment in portfolio company.
J.P. Morgan, New York, NY
Investment Banking Analyst, 2011-2013
Analyzed mergers, acquisitions,
divestitures, equity and debt capital
raises, and other strategic alternatives.
Managed junior deal teams across
multiple product groups on $5B+ of
completed equity and debt transac-
tions, and sell-side M&A transaction.
Ranked in top quartile for all perfor-
mance reviews; received third-year
analyst offer.
Marcus S. Moreno
Harvard University, Cambridge, MA
A.B., Economics, 2008
An opportunity to improve care delivery
and reshape the patient experience.
Rezilir Health, Boca Raton, FL
Director of Product Development,
Summer 2016
Designed beta version of the compa-
ny’s first product — patient-centric
health and wellness packages — to
make living healthy simple. Developed
market entry and pricing strategy
based on market segmentation and
competitive landscape assessment.
Curated list of 100+ potential partner
communities resulting in first commu-
nity partnership.
CVS Health, Northbrook, IL
Product Innovation Senior Advisor,
2014-2015
Product Innovation Advisor, 2012-2013
Developed and led initiative to expand
the product pipeline; engaged cross-
functional team of 35 resulting in 6
product concepts to be prototyped
and tested. Embedded new innovation
capabilities by facilitating workshops
to train more than 100 colleagues and
clients in innovation processes. Led
team developing enterprise strategy
options to reduce total client phar-
macy costs and grow enterprise share.
Rezilir Health, Weston, MA
Consultant, 2011-2012
Senior Analyst, 2009-2011
Analyst, 2008-2009
Led life sciences projects focused on
developing go-to-market strategies,
product portfolio optimization, and
due diligence. Performed as team
leader designing analyses and research
instruments, developing dynamic mod-
els, conducting interviews and surveys,
and coordinating day-to-day activities.
David E. Mishkin
Washington University, St. Louis, MO
B.S., Finance, 2009
An opportunity to operate and invest
in innovative healthcare services and
technology companies.
Oak HC/FT, Greenwich, CT
MBA Intern, Summer 2016
Formulated investment thesis and
sourced potential investments in the
health insurance space. Conducted due
diligence, including thorough valua-
tion, operational, financial, legal and
regulatory review of companies in the
pharmacy and network management
sectors.
Sandbox Industries, Chicago, IL
Vice President, 2014-2015
Associate, 2013-2014
Analyst, 2012-2013
Managed a $325M venture fund in-
vesting in seed through growth equity
stage healthcare and technology com-
panies. Prospected and sourced over
250 new investment opportunities.
Engaged in every aspect of the invest-
ment process, participating in 8 new
and follow on financings. Actively
supported 6 portfolio companies by
attending board meetings; assisted
with financial planning, development,
recruiting, and sales; generated $55M
in sales contracts between our
portfolio companies and our health
plan investors.
Barclays Capital, New York, NY
Investment Banking Analyst, 2010-2012
Executed financial models to assess
M&A transactions and capital structure
alternatives.
25
Vinayak S. Nikam
Duke University, Durham, NC
B.S., Biology with Honors, History, 2012
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2017
An opportunity to bring life-changing
therapies to the patients who need
them.
SR One, Ltd., San Francisco, CA
Summer Associate, Summer 2016
Evaluated investment opportunities
for a life sciences-focused venture cap-
ital firm. Assisted in the daily opera-
tions of a biotech start-up undergoing
incubation by the firm. Conducted
four therapeutic area assessments for
an oncology start-up in the firm’s in-
vestment portfolio.
Regeneron Pharmaceuticals, Inc.,
Tarrytown, NY
Business Development Intern, Summer 2016
Investigated scientific and commercial
rationale for expansion of pipeline
antibodies to additional therapeutic
areas in oncology. Directed team of
clinical, manufacturing and financial
personnel to evaluate strategic part-
nership opportunities in industrial
operations. Conducted due diligence
on three strategic partners to inform
potential deal negotiations and
partnerships in inflammation and
pain space.
Zeno Pharmaceuticals, San Diego, CA
Strategy Intern, 2015-2016
Performed market landscape analysis
of multiple oncology therapeutic areas
for two novel small molecule inhibi-
tors. Identified and analyzed potential
partners to fund continued research
and development.
Andrew R. Neill
Texas Christian University, Fort Worth, TX
B.B.A, Finance, 2008
An opportunity to invest in and/or
launch and develop early-stage biophar-
maceutical companies developing novel
therapeutics for completely unmet
medical needs.
Lumos Pharma, Austin, TX
Corporate Development, Summer 2016
Further developed and implemented
corporate strategies, including future
financing and patient diagnosis and
acquisition strategies. Assisted in the
preparation of Investigational New
Drug Application. Currently manage
budget process in an on-going
manner, among other duties.
Lumos Pharma, Austin, TX
Co-Founder, Business and Corporate
Development, 2011-2015
Identified and in-licensed a novel
treatment for the rare disease Creatine
Transporter Deficiency. Raised $14M
Series A from New Enterprise
Associates, Santé Ventures, and UCB.
Company has since raised a $34M
Series B. Developed and managed pro
forma financials. Secured key collabo-
rations with the National Institutes of
Health’s Therapeutics for Rare and
Neglected Diseases Program and the
UK’s Wellcome Trust. Developed com-
mercial model, including epidemiology
and market assessments. Managed
hiring of key personnel and aspects of
non-clinical and clinical development
plan. Interfaced directly with Board
of Directors.
Innovations in Drug Development (id2),
Austin, TX
Analyst, 2009-2015
Conducted due diligence on prospec-
tive investment opportunities in the
life sciences and healthcare industries.
Daniel G. Mulreany
Johns Hopkins University, Baltimore, MD
B.S., Biomedical Engineering,
Electrical Engineering, 2005
M.S.E., Biomedical Engineering, 2010
An opportunity to work in the
biotechnology industry, at the
intersection of science and business.
Amgen, Thousand Oaks, CA
Intern, Business Development, Summer 2016
Developed new evaluation methodol-
ogy for device and digital health tech-
nologies in support of CEO strategic
initiative to improve competitiveness
and patient experience.
Corporate Executive Board,
Washington, DC
Senior Analyst, Corporate Strategy &
Development, 2014-2015
Senior Research Analyst, 2013-2014
Designed and implemented a
firm-wide strategic planning process,
achieving coordination following
a major acquisition. Evolved global
partnership strategy, advancing
CEB’s position in global markets
on 6 continents.
Human Genome Sciences, Rockville, MD
Image Analyst, Immunology and Oncology
Research Departments, 2011-2012
Led implementation of $500,000
investment in pre-clinical imaging,
accelerating development of 12+ new
drug candidates. Produced integral
data for two Investigational New Drug
applications. Won company-wide
competition for project visualizing
drug efficacy.
Johns Hopkins University, Baltimore, MD
Research Biomedical Engineer, 2005-2008
Utilized novel biomedical imaging
techniques to advance understanding
and treatment of lung disease.
Authored 6 publications in high-
impact journals. Designed new
ventilator control system, enabling
experiments that verified a key
hypoth esis in lung disease manage-
ment.
26
Margot D.
Prendergast
margot.prendergast.wg17@
wharton.upenn.edu
Boston College, Chestnut Hill, MA
B.S., Magna Cum Laude, Finance, 2009
An opportunity to bridge the gap
between corporate and non-profit
global health delivery.
Novartis, East Hanover, NJ
MBA Associate, Finance Development
Program, Summer 2016
Worked as a member of the U.S.
General Medicines business unit
finance team; analyzed brand perfor-
mance drivers and generated new KPI
reports, developed and tested demand
forecasting models, and supported
annual budget process.
Partners In Health, Neno, Malawi
Program and Operations Coordinator,
Global Health Corps Fellow, 2014-2015
Selected for one of 128 Global Health
Corps fellowship positions from appli-
cant pool of nearly 5000 candidates.
Implemented new inventory manage-
ment system supporting district
hospital in rural, resource poor
environment. Drove logistics and
purchasing to rapidly scale disaster
response following historic flooding
and declaration of natural disaster.
Partners HealthCare System, Boston, MA
Business Analyst, Partners HealthCare
International, 2012-2014
Contract Data Analyst, 2010-2012
Delivered analytical support to drive
international business development
initiatives, including investment
in international referral channels.
Supported hospital supply chain
management through contract data
analytics.
Jordan M. Pecherer
University of Michigan, Ann Arbor, MI
B.S., Biochemistry, 2010
An opportunity to build leading health-
care businesses through investment or
management.
J.P. Morgan Chase, San Francisco, CA
Summer Associate, Healthcare Investment
Banking, Summer 2016
Contributed to execution of a large-
cap biotech M&A transaction follow-
ing activist defense. Conducted
financial analysis and process support
for debt and equity financing transac-
tions for mid- to small-cap biotechnol-
ogy and medical device companies.
IndUS Growth Partners, Boston, MA
Private Equity Associate, 2015
Led proactive sourcing, evaluation and
proposed deal structuring for prospec-
tive acquisitions and led post-merger
integration and portfolio company
strategy for completed acquisitions
for private equity firm with $2B under
management. Executed transactions
in the healthcare data and analytics
(Activate Networks) and hospital
market research (Healthcare Business
Insights) sectors.
Decision Resources Group,
Burlington, MA
Consultant, 2012-2015
Consultant to the biopharmaceutical
and medical device industries.
Contributed to and led teams through
over 30 engagements focused on
assessing the commercial opportunity
for pharmaceutical and medical device
products in both emerging and devel-
oped markets. Engagements focused
on market opportunity assessments,
revenue forecasting, clinical trial strat-
egy, regulatory and reimbursement
strategy, and licensing and acquisition
strategy.
Norman L. Pai
Rice University, Houston, TX
B.S., Cum Laude, Electrical Engineering, 2011
An opportunity to leverage my technol-
ogy and analytics experiences to im-
prove healthcare data applications.
HealthVerity, Philadelphia, PA
Product Manager, Summer 2016
Led a team of 4 engineers to complete
3 product roadmap milestones on time
including Marketplace platform
launch. Bridged communication gaps
across founders, analytics & engineer-
ing. Transformed development from
Kanban to Scrum process. Hosted 9 UI/
UX and technical design sessions yield-
ing new data models and user flows.
Slalom Consulting, San Francisco, CA
Information Management and Analytics
Consultant, 2013-2015
Created and steered internal Data
Science group. Supported $1.5M+ of
advanced analytics engagements. Built
predictive models to improve generic
drug launch accuracy by 4X. For
various clients, produced Tableau-R
dashboards, developed data ware-
houses, and conducted data analysis
affecting management decisions.
Accenture, San Francisco, CA
Business Intelligence (BI) Consultant,
2012-2013
Innovation Centers for SAP Solutions &
Mobile Technology Analyst, 2011-2012
Designed and deployed Accenture
iPad app to App Store: as product
owner and content creator, shaped
director’s idea into cross-industry
showcase used by 500+ executives
worldwide. Made 2 interactive iPad
app prototypes, architected 15+
decision tools for Fortune 500 clients
and reduced data analysis time by
over 95%.
27
Steven F. Rizzo
Cornell University, Ithaca, NY
B.S., Cum Laude, Applied Economics
& Management, 2010
An opportunity to work with a dynamic
team to develop and execute strategy
for health care companies.
Deloitte Consulting, Philadelphia, PA
Strategy & Operations Summer Associate,
Summer 2016
Advised on a corporate strategy re-
fresh for a Fortune 500 pharmaceutical
company. Designed survey instruments
to identify and prioritize key corporate
strategy initiatives. Moderated inter-
views with Deloitte leaders on analyt-
ics best practices; synthesized and
shared learnings that informed
restructuring of the client’s 300
person, $250M internal analytics
group.
Navinata Health, Princeton, NJ
Director of Operations, 2015
Collaborated on the design and devel-
opment of the company’s first technol-
ogy offering — an online platform
enabling information exchange & edu-
cation between Pharmaceutical com-
panies and Physicians. Negotiated the
selection of multiple partners related
to website design, data visualization
and survey development, key compo-
nents for the creation of the platform.
ZS Associates, Princeton, NJ
Associate Consultant, 2013-2015
Business Associate, 2010-2012
Sales and Marketing strategy consult-
ing for pharmaceutical and biotech
firms, with an emphasis on oncology
and cardiovascular disease. Managed
client relationships and led cross-func-
tional teams in qualitative and quanti-
tative market strategy projects.
Designed research instruments and an-
alytical methods to inform commercial
strategy.
Jon Michael Reese
Vanderbilt University, Nashville, TN
B.A., Economics, 2010
An opportunity to identify, build
and direct market-leading healthcare
companies through an equity
investment role.
Citadel, New York, NY
Surveyor Capital Summer Associate,
Summer 2016
Initiated long / short equity coverage
of subsectors within healthcare,
transportation and business services.
Completed business diligence and pre-
sented investment recommendations
resulting in portfolio investments.
Accurately predicted EPS and direc-
tional share price movement for the
two companies in coverage space that
reported quarterly earnings.
GTCR, Chicago, IL
Senior Associate, 2014-2015
Associate, 2012-2014
Originated and led private equity
transactions across 4 platforms in
healthcare industry including invest-
ments in outsourced contract steriliza-
tion (Sterigenics International), life
sciences tools and diagnostics (Cole-
Parmer Instruments), healthcare ser-
vices to correctional institutions (CHC),
and independent pharmacy software
(Rx30) sectors. Identified attractive
segments within healthcare industry,
analyzed market characteristics,
constructed detailed financial models,
directed due diligence efforts, and
participated in board meetings.
Bank of America Merrill Lynch,
New York, NY
Analyst, 2010-2012
Completed 43 high yield bond and
leveraged loan offerings with total
aggregate value of over $24B to sup-
port leveraged buyouts, recapitaliza-
tions, and refinancings.
Michael Rahman
St. Olaf College, Northfield, MN
B.S., Cum Laude, Economics and Psychology,
2012
Level III CFA Candidate
An opportunity to work on a dynamic
team within health care services or IT,
with responsibility for strategic finance
and other operational initiatives.
Brighton Health Plan Solutions,
New York, NY
Intern, Summer 2016
Worked with the CEO of Brighton
Health Plan Solutions and led initia-
tives across strategic finance, business
development, network strategy and
cost containment operations.
Presented 2016 budget, five-year
financial forecast and unit economics
to the Board of Directors and achieved
financing to support newly launching
company. Led contract negotiation
and implementation with an out-of-
network cost containment vendor.
UnitedHealth Group, Minnetonka, MN
M&A Associate, 2012-2015
Corporate M&A team reporting to
the CFO of UnitedHealth Group,
responsible for acquisitions at
UnitedHealthcare and Optum. Worked
with senior executives to forecast
target company financials, conducted
valuation analysis and assessed finan-
cial returns of potential acquisitions.
Collaborated with executives to coor-
dinate due diligence and evaluate
strategic fit, synergies and integration
costs.
28
Barthalomew A.
Sillah
Harvard University, Cambridge, MA
A.B., Human Developmental and Regenerative
Biology, 2012
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2017
An opportunity to combine my clinical
training and business experience to
improve health systems management
and business development.
University of Pennsylvania Health
System, Philadelphia, PA
Administrative Fellow, Summer 2016
Structured partnerships and medica-
tion dispensing agreements with key
pharmaceutical companies increasing
department revenue by $26M.
Directed a lean transformation
initiative to increase patient flow
in the outpatient oncology clinic.
Excelsior Group, Nairobi, Kenya
Fellow, Summer 2015
Conducted investment due diligence
of private pharmaceutical, medical
devices and health services companies.
Advised a portfolio company in key
strategic decisions and business model
redevelopment.
King’s Sierra Leone Partnership,
Freetown, Sierra Leone
Hospital Administration Intern, Summer and
Fall 2013
Developed and implemented a survey
tool to integrate patient feedback into
administrative operation decisions.
Performed a lean transformation
with the billing and collections office
increasing bed turnover by 15%.
Identified hygiene education methods
that helped decrease hospital acquired
infection rates by 24%.
Viba Saligrama
Georgetown University, Washington, DC
B.S., Summa Cum Laude, Business
Administration, 2011
An opportunity in strategy or
operations to improve value in health
care delivery and focus on wellness
and prevention.
DaVita Healthcare Partners, Denver, CO
Redwoods Summer Associate, Summer 2016
Led a project exploring impact of
patient experience on clinical and
business outcomes for primary care
practices. Conducted 40 interviews
and reviewed secondary research to
develop framework. Analyzed patient
satisfaction survey data from 100+
clinics to identify correlations between
survey results and key performance
metrics, including hospital utilization
and member growth rates. Provided
recommendations to improve patient
experience and inform future invest-
ments.
Deloitte Consulting, Washington, DC
Consultant, 2013-2015
Analyst, 2011-2013
Strategy and operations consultant
for U.S. government healthcare agency
clients. Project work included strategic
planning, resource allocation, program
evaluation and process improvement.
Developed Defense Health Agency’s
long-term prevention strategy and
managed the design, marketing and
implementation of 5 public-health
pilot projects on nine military bases.
Analyzed 10 business plans to support
an ACA financing program. Designed a
prioritization process to better allocate
$1B budget spent on food safety.
Reviewed proposals to improve
Veteran health and built data man-
agement tools to support budgeting
decisions.
Riddhi Roy
Carnegie Mellon University, Pittsburgh, PA
B.S., M.S., with University Honors, Chemistry,
2010
An opportunity to impact patients
through a commercial strategy role
in a life sciences company.
Genentech, South San Francisco, CA
Commercial Intern in Pricing, Contracting,
and Distribution, Summer 2016
Led assessment of specialty drug distri-
bution centers for infused products.
Analyzed risks and developed strategic
recommendations around how to treat
distribution centers, pre- and post-bio-
similar launch. Presented recommen-
dations to functional leadership.
Deloitte Consulting, Pittsburgh, PA
Consultant, 2013-2015
Business Analyst, 2011-2013
Gained experience with health plan,
provider, and life sciences sectors.
Focused on pharmaceutical and
biotech industry, worked on projects
ranging from R&D operations to
commercial strategy. Performed R&D
spend benchmarking assessment
for global pharmaceutical company
through peer company interviews
to inform annual R&D budget.
Coordinated relaunch activities for
two acquired assets and conducted
workshop to determine long-term
therapeutic area portfolio strategy.
Quality of Life Technology Foundry,
Pittsburgh, PA
Foundry Associate, 2010-2011
Developed and presented business
plans to investors for research
enabling people with disabilities to
live independently. Organized all
logistics and content for company
booth at Consumer Electronics Show,
managed $100K budget, and made
connections to future investors.
Managed summer interns and sup-
ported annual report development.
29
William P. Stratton
Yale University, New Haven, CT
B.S., Intensive Major, Chemistry, 2011
An opportunity to help grow an
innovative biopharmaceutical company
through business development or
commercial strategy.
Cidara Therapeutics, San Diego, CA
Business Development and Marketing Intern,
Summer 2016
Examined potential M&A candidates
based on therapeutic and strategic
alignment with Cidara’s development
programs. Assessed the potential for
an alternative route of administration
for Cidara’s lead candidate (CD101)
and delivered a strategic plan for the
program. Analyzed the addressable
market and commercial opportunities
for new indications for CD101, provid-
ing recommendations on attractive
indications, clinical development
considerations, and lifecycle manage-
ment strategies.
The Amundsen Group, an IMS Health
Company, Burlington, MA
Consultant, 2014-2015
Associate Consultant, 2013-2014
Provided data analytics and strategic
insights to biopharmaceutical clients.
Managed project teams on various
engagements, including market land-
scape assessment, payer control and
contracting strategy, primary market
research, and launch planning.
The Exeter Group, Boston, MA
Consultant, 2011-2013
Project manager at a national,
non-profit blood bank. Supported
the planning and implementation of a
new software system to update blood
labeling and manufacturing processes.
Managed over 150 people delivering
over 1,300 documents used to train
staff on new processes.
George H. Stein
University of Pennsylvania, Philadelphia, PA
B.A., Magna Cum Laude, Economics and
East Asian Studies, 2010
An opportunity to build innovative
health care services and digital health
companies that change care delivery.
UnitedHealth Group Ventures,
Minnetonka, MN
Summer Associate, Summer 2016
Gained exposure to group’s venture
capital investment processes by
supporting two pipeline projects and
working extensively with portfolio
company. Identified 50% revenue
opportunity at start-up in portfolio
by stratifying sales prospects, creating
consistent processes and developing
distinct customer segments and
quantifying customer lifetime value
of each segment.
McKinsey & Company, Washington, DC
Senior Business Analyst, 2014-2015
Business Analyst, 2012-2014
Focused time on technology, strategy,
and operations primarily for health
care and TMT clients. Developed and
built business cases and models for >20
new B2B / B2C products. Created
strategy for developing private ex-
change offering. Identified ~$70M in
opportunities for health care client as
part of organizational transformation.
Designed software reduction program
to achieve savings for EMR business
case.
The Advisory Board Company,
Washington, DC
Senior Analyst, 2011-2012
Analyst, 2010-2011
Developed strategic and operational
expertise — primarily in health IT, phy-
sician topics (engagement, leadership
and hospital-physician contracts) and
care management—related to health
care transformation for providers.
Christopher J. Skayne
Amherst College, Amherst, MA
B.A., Law, Jurisprudence, and
Social Thought, 2011
To improve the delivery and financing
of health care services.
McKinsey & Co., Detroit, MI
Summer Associate, Summer 2016
Advised leading health care company
on the creation of a health care
services subsidiary. Created strategic
vision documents, counseled on buy vs.
build decision for a new technology,
and developed long-term financial
forecasting tool.
athenahealth, Watertown, MA
Senior Associate Corporate Strategy,
2013-2015
Senior Associate Business Development,
2012-2013
Conducted due diligence and executed
acquisition of publicly traded
Epocrates, Inc. – developer of most
used mobile app in health care – for
$307M. Managed post-acquisition in-
tegration work streams; presented to
athenahealth CFO the achievement of
$10M+ in cost-savings synergies. Led
a revamp of business’s Customer
Relationship Management system to
increase efficiency and give manage-
ment visibility into the $100M+ sales
pipeline. Developed commercial turn-
around strategy for business unit’s free
mobile application; led launch of new
ad-unit to successfully drive renewed
sales momentum.
Cambridge Associates, Boston, MA
Consulting Associate, 2012
Worked across teams of consultants,
specialists, and investment analysts on
nine unique client teams, conducting
analyses, tailoring investment recom-
mendations, and presenting findings
to university and museum investment
boards.
30
Alex Wittenberg
Stanford University, Palo Alto, CA
B.A. with Distinction, Phi Beta Kappa,
International Relations, 2012
An opportunity in impact investing or
general management with a company
focused on products or services that
improve global health.
The Global Health Investment Fund,
New York, NY
Summer Associate, Summer 2016
Led diligence on a novel therapeutic
for soil-transmitted helminthiases,
evaluating the financial upside, global
health impact, and technical and
regulatory risks of financing the drug’s
development and commercialization.
Created impact model quantifying the
number of lives saved and improved
from existing investments in diagnos-
tics, drugs, and vaccines.
Bain & Company, Los Angeles, CA
Senior Associate Consultant, 2014-2015
Associate Consultant, 2012-2014
Strategy consultant across sectors
including private equity, media &
entertainment, and biotechnology.
Biotechnology projects spanned
shared services design & organiza-
tional strategy and process mapping
and optimization.
The Bill & Melinda Gates Foundation,
Seattle, Washington
Strategy Consultant, 2014-2015
(on externship from Bain & Company)
Coordinated working team of six
scientists and led strategic initiatives
for a new program investing in inno-
vations to treat preterm birth, growth
stunting, and neurocognitive deficits
in developing countries. Organized
and facilitated budgeting sessions to
allocate $150M to global health clini-
cal trials and technology development.
Fiona Tang
University of Michigan, Ann Arbor, MI
B.S., With Distinction, Economics and
Mathematics, 2011
An opportunity to work on or build
elder care services in China.
Goldman Sachs, Hong Kong, China
Summer Associate, Summer 2016
Worked on a variety of projects to
provide financial advisory to Chinese
clients ranging from IPO, private
placement and M&A.
Capital One, Wilmington, DE
Senior Analyst, 2013-2015
Built and executed marketing and
product strategies for Capital One 360.
McKinsey & Company, Pittsburgh, PA
Business Analyst, 2011-2013
Provided strategy consulting services
to providers, payors and pharmaceuti-
cal companies on healthcare reform
strategy, organization restructure,
acquisition strategies and etc.
Michael L. Suiters
Davidson College, Davidson, NC
B.A., History, 2010
An opportunity to build transforma-
tional healthcare technology and
services companies as an operator
or investor.
Oxeon Ventures, New York, NY
Summer Senior Associate, Summer 2016
Co-wrote the business plan for spin-
ning out technology developed within
a leading $6B Integrated Delivery
Network (IDN) into an independent
start-up. Led financial feasibility and
competitive analyses and presented
recommendations to IDN leadership
en route to a “green light” funding
decision. Supported Oxeon’s first
limited partner fundraise including the
economic analysis of venture capital
fund structures and development of
limited partner recruitment materials.
Evolent Health, Arlington, VA
Director, Strategy 2015
Associate Director, 2013-2014
Senior Analyst, 2012
Accelerated Evolent Health’s growth
from Series A to $1B+ IPO while
contributing cross-functionally across
corporate strategy, sales, finance,
and operations. Most recently advised
senior management on the value
and relative prioritization of growth
initiatives including new product
development, new market entry, and
acquisitions, and partnered with senior
executives to rollout initiatives.
Deloitte Consulting, Washington, DC
Consultant, 2012
Analyst, 2010-2012
Analyzed implications of healthcare
reform for clients and the Deloitte
Center for Health Solutions.
31
Linan Xiao
Duke University, Durham, NC
B.S., Biology, 2009
An opportunity to improve quality,
value and access to cutting edge
healthcare innovations.
Amgen, Thousand Oaks, CA
Commercial Leadership Program,
Summer 2016
Spearheaded launch preparations for
new indication of in-line hematology
drug. Reassessed commercial opportu-
nity and conducted customer research
to identify patient segments, clinical
unmet needs and opportunities.
Determined product positioning and
core value messages by interfacing
with clinical trial leaders, customers
and sales team. Recommended
optimal sales force & non-personal
tactics based on ROI analysis.
IMS Consulting Group, New York, NY
Consultant, 2014-2015
Associate, 2012-2014
Analyst, 2010-2012
Market access and commercial strategy
consultant for pharmaceutical, biotech
and medical device companies.
Managed teams of associates in
conducting qualitative and quantita-
tive engagements, to provide recom-
mendations to sales and marketing
executives in U.S., E.U. and global
emerging markets. Created and
launched global and local pricing
strategies; other project experience
spans clinical development, value
messaging, life cycle management,
launch excellence, health economics
and policy advocacy.
Amanda B. Wyatt
Harvard College, Cambridge, MA
A.B., Cum Laude, Social and Cognitive
Neuroscience, 2012
An opportunity to grow innovative life
sciences products and impact patients
through a marketing role in the
biopharmaceutical industry.
Pfizer, New York, NY
Marketing MBA Summer Associate,
Summer 2016
Spearheaded national educational
program with 50 sessions for health
care professionals in advance of high-
profile label update; worked closely
with medical, regulatory, and legal
colleagues to develop content at risk,
a first for the division. Conducted
analysis on reach and engagement
of previous programs, ultimately
recommending new program format
to maximize ROI adopted by the
team lead.
TribalVision, Boston, MA
Project Leader, 2014-2015
Consultant, 2013-2014
Associate, 2012-2013
Marketing and strategy consultant for
midsized firms, including medical
device manufacturers, health centers,
and technology service providers. As a
Project Leader, concurrently managed
4-6 client accounts, domestic and inter-
national, with 6 direct reports. Built a
new e-commerce solution for a U.S.
device manufacturer; increased online
sales by 18% and order volume by
14%. Designed ACA communications
strategy for a non-profit health center,
helping to educate and ultimately en-
roll 1300 formerly uninsured patients.
Completed market entry strategy
for Korean device manufacturer,
evaluating $1.2 billion U.S. market
opportunity.
Christina M. Wray
Dartmouth College, Hanover, NH
B.A., Magna Cum Laude, Biology with
High Honors, 2012
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2017
An opportunity to promote medical
device innovation and the commercial-
ization of new surgical technologies.
Action Potential Venture Capital,
Palo Alto, CA
MBA Summer Associate, Summer 2016
Evaluated investment opportunities
and conducted investment diligence
on companies in the bioelectronic
medicine space. Conducted a market
overview to evaluate promising novel
therapies in a specific disease area.
Worked directly with a portfolio
company to design a study to inform
product design specifications.
University of Pennsylvania Department
of Otolaryngology, Philadelphia, PA
Research Assistant, 2014-2016
Conducted a literature review on
clinical outcomes and quality of life
following a novel treatment for
obstructive sleep apnea. Evaluated the
effect of commercial thickening agents
on the perceived palatability of
liquids. Documented the first-ever
report of a hypopharyngeal malig-
nancy arising in a field of Crohn’s
disease.
32
Jaeyoung Yang
Yale College, New Haven, CT
B.A., Economics and International Studies,
2009
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2017
A clinical and strategy role with a health
services company focused on innovative
care models.
Iora Health, Boston, MA
Summer Associate, Summer 2016
Developed referral management pro-
gram for a national chain of primary
care clinics with emphasis on clinical
follow-up, user experience, and
operational efficiency. Established five
market-based call centers for 43 staff
to support $3M patient recruitment
effort.
Office of Clinical Effectiveness and
Quality Improvement, University
of Pennsylvania Health System,
Philadelphia, PA
Summer Intern, Summer 2013
Spearheaded successful interdepart-
mental project to reduce length-of-
stay for a high-volume surgery by
identifying key variations in post-op
care in a comparative hospital study
and implementing a ‘fast-track’
pathway (est. $100,000/year saved).
The Camden Coalition of Healthcare
Providers, Camden, NJ
Assistant Project Manager, 2011-2012
Successfully applied for $300,000
in grants for seven staff positions in
care coordination. Established “health
coach” program by negotiating with
AmeriCorps and local providers to
share oversight and funding. Recruited
5 members, led training/onboarding
process, and oversaw operations.
Facilitated multi-stakeholder working
group to promote primary care in a
400-unit low-income housing complex.
33
The following organizations
provided internships for Health Care
Management Students in Summer, 2016.
ACCOLADE
Plymouth Meeting, PA
ACTION POTENTIAL VENTURE CAPITAL
Palo Alto, CA
ALEDADE
Bethesda, MD
AMGEN
Thousand Oaks, CA
ATHENAHEALTH
Watertown, MA
BAIN & COMPANY
Dallas, TX
BANK OF AMERICA
New York, NY
BRIGHTON HEALTH PLAN SOLUTIONS
New York, NY
CIDARA THERAPEUTICS
San Diego, CA
CIGNA
Philadelphia, PA
CITADEL
New York, NY
CLINTON HEALTH ACCESS INITIATIVE
Phnom Penh, Cambodia
CLOVER HEALTH
Jersey City, NJ
COLLABORATIVE HEALTH SYSTEMS
(UNIVERSAL AMERICAN)
White Plains, NY
COMMUNITY VETERINARY PARTNERS
Philadelphia, PA
CYTOMX THERAPEUTICS
San Francisco, CA
DAVITA HEALTHCARE PARTNERS
Denver, CO
DELOITTE CONSULTING
Philadelphia, PA
DOXIMITY
San Francisco, CA
FRAZIER HEALTHCARE PARTNERS
Seattle, WA
FRED ALGER
New York, NY
GENENTECH
South San Francisco, CA
GENEOSCOPY
St. Louis, MO
THE GLOBAL HEALTH INVESTMENT FUND
New York, NY
GOLDMAN SACHS
San Francisco, CA
Hong Kong, China
HEALTHVERITY
Philadelphia, PA
IBM
Austin, TX
INTANDEM CAPITAL PARTNERS
New York, NY
IORA HEALTH
Boston, MA
J.P. MORGAN CHASE
San Francisco, CA
LAZARD
Los Angeles, CA
LEK CONSULTING
Los Angeles, CA
LUMOS PHARMA
Austin, TX
MCKINSEY & COMPANY
Palo Alto, CA
Denver, CO
Chicago, IL
Detroit, MI
Summit, NJ
New York, NY
MEDTRONIC
Santa Rosa, CA
Minneapolis, MN
NEW CAPITAL PARTNERS
Philadelphia, PA
NOVARTIS
East Hanover, NJ
Basel, Switzerland
NUNA HEALTH
San Francisco, CA
OAK HC/FT
Greenwich, CT
OXEON VENTURES
New York, NY
PFIZER
New York, NY
QUARTET HEALTH
New York, NY
REGENERON PHARMACEUTICALS
Tarrytown, NY
REZILIR HEALTH
Boca Raton, FL
RITTENHOUSE VENTURES
Philadelphia, PA
SEATTLE GENETICS
Seattle, WA
SOMNIUM SLEEP SOLUTIONS
New York, NY
SR ONE LTD.
San Francisco, CA
Cambridge, MA
TAKEDA PHARMACEUTICAL COMPANY
Deerfield, IL
TELADOC
Purchase, NY
UAB HEALTH SYSTEM
Birmingham, AL
UNITEDHEALTHCARE
Minnetonka, MN
UNITEDHEALTH GROUP VENTURES
Minnetonka, MN
UNIVERSITY OF PENNSYLVANIA
HEALTH SYSTEM
Philadelphia, PA
VENTUS HEALTH INVESTORS
Philadelphia, PA
WARBURG PINCUS, LLP
Shanghai, China
WELLSHEET
New York, NY
WELLTHIE
New York, NY
WELLTOK
Newport Beach, CA
Internship Sponsors
2016
34
Mentors are leaders and senior managers
in the healthcare field who have agreed to
provide career and professional development
advice and guidance to Health Care
Management Students.
ABHISHEK AGRAWAL
Associate Director, Marketing
Merck Sharpe & Dohme, India
Mumbai, India
EUGENE AN
Group Product Manager
Genentech
South San Francisco, CA
SANJAY ANAND
President and CEO
Bryant Ranch Prepack Pharmaceuticals
Burbank, CA
NICK ANDERSON
Associate
Robert W. Baird
Chicago, IL
HEATHER ASPRAS
Director, New Product Strategy
GlaxoSmithKline
Philadelphia, PA
DARSHAN BACHHAWAT
Director, Health Systems Business
ZocDoc
New York, NY
KENT E. BACKLUND
Director
Pfizer, Inc.
New York, NY
BRENDA J. BACON
President and CEO
Brandywine Senior Living
Mt. Laurel, NJ
TONY BALDA
President & COO
Medicomp, Inc.
Melbourne, FL
GRANT BECHTOLD
Vice President, Corporate and Business
Development
Medsurant Holdings (portfolio co.
New Capital/Volante Capital)
Santa Monica, CA
JAMIL M. BEG
Director of Business Development
SAGE Therapeutics
Cambridge, MA
ALI BEHBAHANI, MD
Partner
New Enterprise Associates
Chevy Chase, MD
ERIC R. BELL
Managing Director
SpringRock Ventures
Seattle, WA
SIGAL BEN-ARI, PHD
COO
Kodu Care
Seattle, WA
RYAN BERGER
Senior Business Strategist
Hearst Health
Los Angeles, CA
ALEXIS BERNSTEIN
Senior Director, Client Services
Wellframe
Boston, MA
KERUN BINDRA
Director, Global Product &
Portfolio Strategy
AstraZeneca
Gaithersburg, MD
DARREN M. BLACK
Managing Director
Summit Partners
Boston, MA
KATHERINE BOCK
Senior Director, Corporate Development
Nevro
Redwood City, CA
DAVID BRILL
Research Analyst
Everpoint Asset Management
New York, NY
ELIZABETH J. CAMPBELL
Vice President
LL Partners
Philadelphia, PA
NICOLE A. CARKNER
Executive Director
Quad City Health Initiative
Davenport, IA
WILLIS CHANDLER
Vice President Health System Alliances
CVS Health
Cumberland, RI
THIERRY CHAUCHÉ
Executive Director, Business Planning
& Analysis
Novartis Pharmaceuticals Corporation
East Hanover, NJ
CHRISTOPHER P. CHEN, MD
Associate; Hospitalist at UW
McKinsey; University of Washington
Medical Center
Seattle, WA
EMILIE COUEIGNOUX CHEN
Senior Manager, Market Planning
Seattle Genetics
Bothell, WA
MARK CHIN
Investment Manager
Arix Bioscience
New York, NY
AMY CHIU
Manager, Strategy and Business
Development
Sutter Health
San Francisco, CA
BRIAN CHOI, MD
Chief Medical Information Officer;
Associate Professor of Medicine & Radiology
George Washington University
Washington, DC
RYAN COCHRAN
Corporate Strategy
CarePoint Health System
Jersey City, NJ
TERI CONDON
Vice President, Strategy and
Business Development
QuantiaMD, a Subsidiary of
Physician’s Interactive
Waltham, MA
DEREK J. CONOVER, DMD
Dentist
Noble Dental Conover,
Leonard and Associates
Philadelphia, PA
ANA CRESPO
Product Marketing Manager
SI-BONE, Inc.
San Jose, CA
LISA DAVID
President and CEO
Public Health Solutions
New York, NY
MORLI DESAI
Director of Strategy and Commercialization
Medtronic (Division: Surgical Innovations
Value Segment)
Atlanta, GA
SALIL V. DESHPANDE, MD
Chief Medical Officer
UnitedHealthcre Community Plan of Texas
Sugar Land, TX
Health Care Program Mentors
2016
35
PITAMBER “PITOU” DEVGON, MD
President, Co-Founder
Velano Vascular, Inc.
Philadelphia, PA
SUJIT DIKE
Area Vice President, Strategic
Account Management
Johnson & Johnson
Eagleville, PA
TANIA DIMITROVA
Director, Worldwide Business Development
Pfizer Inc.
New York, NY
BEN DORANZ, PHD
President and Chief Executive Officer
Integral Molecular, Inc.
Philadelphia, PA
MINA KHOSRAVI EGAN
Managing Director,
Population Health Solutions
The Advisory Board Company
Washington, DC
RAMI ELGHANDOUR
President
Nevro Corp.
Redwood Shores, CA
MYRIAM EXUMÉ
US Marketing Leader, CV Franchise
Merck
North Wales, PA
DANIEL FAGA
Chief Business Officer
Spark Therapeutics
Philadelphia, PA
SAMUEL S. FAGER, MD, JD
President
S.S. Fager Consulting, Inc.
Villanova, PA
MICHAEL FAZEKAS
Vice President
Flexpoint Ford
Chicago, IL
DOUGLAS FISHER, MD
Partner
InterWest Partners
Menlo Park, CA
PETER FISHMAN
Director of Clinical Integration
CarePoint Health
Jersey City, NJ
AARON FLINK
Principal
McKesson Ventures
San Francisco, CA
ERIC FLYCKT, MD
VP Informatics
Jiff Inc.
Mountain View, CA
CHRIS FRANCK
Principal, Life Sciences and Health Care
Deloitte Consulting LLP
Parsippany, NJ
TOMMY (YINING) FU, MD
Resident Physician - Emergency Medicine
Duke University Hospital
Durham, NC
ADRIAN GALE
Senior Manager, Marketing
Nevro Corp.
Redwood City, CA
J.P. GALLAGHER
Chief Operating Officer
NorthShore University HealthSystem
Evanston, IL
MIKE GALLAGHER
Principal
H.I.G. Capital
Miami, FL
ALLISON GAW
Director, Scientific and
Corporate Development
ProNAi Therapeutics
Vancouver, BC
SEAN GLEESON, MD
President
Partners For Kids,
Nationwide Children’s Hospital
Columbus, OH
BRIAN P. GOLDSTEIN, MD
Executive Vice President and
Chief Operating Officer
UNC Hospitals
Chapel Hill, NC
GARY L. GOTTLIEB. MD
President and Chief Executive Officer
Partners in Health
Boston, MA
VIKAS GOYAL
Principal
SR One
Cambridge, MA
TODD GUREN
Assistant Director, Product Management
Regence BlueCross BlueShield
Portland, OR
ALISON HAGAN
Principal
Deloitte Consulting
San Francisco, CA
LINDSAY RAND HERMAN
Program Manager, Strategic Planning
& Business Development
Northwestern Medicine
Chicago, IL
VLAD HOGENHUIS, MD
Senior Vice President Pharmaceuticals
GlaxoSmithKline
Brentford, London, UK
JARED P. HOPKINS
Director, Strategic Finance and Business
Consulting
University of Michigan Health System
Ann Arbor, MI
JERRY HSU
Manager
Deloitte Consulting
San Francisco, CA
ROB A. HULICK
Vice President
Alleghany Capital Corporation
New York, NY
OREN K. ISACOFF, MD
Vice President
Longitude Capital
Greenwich, CT
DANIEL J. KARP
VP, Worldwide Business Development
Pfizer, Inc.
New York, NY
JOYCE KIM
Manager, Service Line Performance
Improvement & Data Analysis
Main Line Health
Bryn Mawr, PA
MICHAEL KOBY
Partner
1315 Capital
Philadelphia, PA
MICHAEL KRAUTKRAMER
Vice President Operations
Avid Radiopharmaceuticals
Philadelphia, PA
DAVID LAMACCHIA
Vice President, Corporate Development
Prospira PainCare
Roswell, GA
RICHARD LEE, MD
Assistant Professor
Weill Cornell Medical College
New York, NY
ADAM LESSLER, MD
Vice President
Canepa Healthcare, LLC
New York, NY
LAUREN LISHER
Principal
Oxeon Partners
New York, NY
JEFFREY LITWIN, MD
President
Litwin Consulting
West Windsor, NJ
WENDY LIU
Senior Director, External Opportunities
Pfizer
New York, NY
JUSTIN LORING
Director, Business Development
Natera
Redwood City, CA
GABRIEL LUFT
Vice President
Amulet Capital Partners
Greenwich, CT
36
ROBERT C. MCDONALD, MD
President
Aledo Consulting
Indianapolis, IN
KAREN MEADOR, MD
Managing Director
BDO Consulting
New York, NY
RAJJI MEHDWAN
Head of Marketing and Strategy
Genentech Roche Denmark
Klampenborg, Copenhagen, Denmark
MICHAEL C. MENG
Principal
Apax Partners
New York, NY
AUDREY MEYERS
President/CEO
The Valley Hospital/Valley Health System
Ridgewood, NJ
GEOFF MEYERSON
Managing Director and Co-Founder
Locust Walk
Cambridge, MA
GREG MILLHAUSER
Vice President and
Portfolio Manager, Private Investments
Glenmede
Philadelphia, PA
REGAN MURPHY
VP, Client Success
Valence Health
Chicago, IL
LAURIE MYERS
Global Health Literacy Director
Merck & Co., Inc.
North Wales, PA
TY NELSON
EVP
Health Carousel LLC
Cincinnati, OH
WES NURSS
Analyst
Marshall Wace
New York, NY
JAMES O’CONNELL
Start-Up
Downingtown, PA
JUSTIN PALLARI
Chief Executive Officer
TransformativeMed
Seattle, WA
KALYAN PAMARTHY
Sr. Product Manager
Jiff, Inc.
Mountain View, CA
SHAUNAK PARIKH
Vice President
Essex Woodlands
New York, NY
ELIZABETH KIERMAN PATTYN
Director of Life Sciences
Truveris
New York, NY
JONATHAN PEARLSTEIN
Director of Growth Marketing
Jiff
Oakland, CA
JENNIFER PERRY
Vice President, Health Care
FMG Leading
San Diego, CA
CARY G. PFEFFER, MD
Partner
Third Rock Ventures
Boston, MA
DAVID PINKERT
Co-Founder and COO
Canopy Health Insurance, Inc.
Denver, CO
SALLY POBLETE
Founder and CEO
Wellthie
New York, NY
LEN PODOLSKY
VP, Partnership Development
Veterinary Practice Partners
Philadelphia, PA
DARSHAN PRABHU
Executive Director
UBS Investment Bank
New York, NY
HENRY RATH
Vice President, Business Development
Seres Therapeutics
Cambridge, MA
DONNA BRADY RAZIANO, MD
Chief Medical Officer
Mercy Health System, Mercy Home
& Community Health Services
Philadelphia, PA
KATE REED, RN
Chief Strategy Officer
Beth Israel Deaconess Medical Center
Boston, MA
SANDRA RETZKY, DO, JD, RPH, MBA, MPH
Associate Director/Global Analytics and
Intelligence
AstraZeneca
Gaithersburg, MD
JAMES RHODES
Director, Business Development
Children’s Health System of Texas
Dallas, TX
BEN M.W. ROOKS
Managing Director
ST Advisors, Inc.
San Francisco, CA
JULIE YOUNG ROTH
Director, Oncology, Infusion, Pallative Care
Services Line
Palo Alto Medical Foundation/Sutter Health
Palo Alto, CA
MICHAEL ROVINSKY
Director, Southeast Region
Veralon
Atlanta, GA
JON ROZENFELD
President and Chief Operating Officer
St. Mary’s Hospital
Madison, WI
ANIL SAGGI
Category Marketing Manager
Nordics, Consumer Health
GlaxoSmithKline Consumer Health
Solna, Sweden
JOE SCATTERGOOD
Senior Marketing Manager,
Oncology Global Marketing
AbbVie
Mettawa, IL
STEVE SCHRODEL
Vice President, Operations
Iora Health
Boston, MA
DAVID M. SCHUPPAN
Partner
Cressey & Company LP
Chicago, IL
JOHN SCHWARZ
Vice President, Administration
Lankenau Medical Center /
Main Line Health
Wynnewood, PA
REBECCA SCHWIETZ
Senior Vice President, Clinical Services
HealthFirst
New York, NY
KENNETH C. SEGARNICK
Chief Corporate Officer
Brandywine Senior Living
Mt. Laurel, NJ
ANKIT SHAH
Director of Marketing
Intersect ENT
Menlo Park, CA
SHERI SHAPIRO
Senior Vice President
Mergers Acquisitions & Partnerships
Trinity Health
Detroit, MI
DAVID SILK
Senior Account Executive
Google
New York, NY
JAMES STANFORD
Managing Director
Fitzroy Health LLC
New York, NY
SUSAN STIMSON
Vice President of Marketing
& International Sales
Intersect ENT
Menlo Park, CA
Health Care Program Mentors
37
JONATHAN TAMIR
Vice Chair, Finance & Administration,
Department. of Medicine
Columbia University Medical Center
New York, NY
AMANDA HOPKINS TIRRELL
Chief Operating Officer
Georgia Regents Medical Associates
Augusta, GA
FERNANDO TORRES
Practice Lead
Himformatics
Cummings, GA
BARBARA TROUPIN, MD
SVP, Chief Medical Officer
Apricus Biosciences
San Diego, CA
MAYA TSUKERNIK
Project Leader
The Boston Consulting Group
New York, NY
JOHN A. URQUHART
Vice President
HealthCare Royalty Partners
Stamford, CT
JEFF VOIGT
Principal
Medical Device Consultants
of Ridgewood
Ridgewood, NJ
JOHN VOITH
Director and Product Manager
athenahealth
Watertown, MA
DAVID WALTON
Chief Commercial Officer
AgaMatrix, Inc.
Salem, NH
DONG WEI, PHD
Senior Director, Business Operations
and Project Management
Johnson & Johnson
Menlo Park, CA
ANDREW WEISENFELD
Partner
MTS Health Partners
New York, NY
CHRIS WILKERSON
President
EquipSystems, LLC
New York, NY
HELENE WOLK
Senior Vice President of Operations
Englewood Hospital and Medical Center
Englewood, NJ
JON YEATMAN
Vice President, Strategic Growth
and Business Development
Mission Health
Asheville, NC
DANIEL YIP
Head of U.S. Marketing
Intercept Pharmaceuticals
New York, NY
ELLEN S. YOON
Global Cognitive & Analytics Insurance
Leader, GBS Partner
IBM Corp.
New York, NY
DEREK H. YUAN, MD
Director
PharmaEssentia Corp.
Taipei, Taiwan
XIN SHANE ZHANG, PHD
Marketing Director
Smith&Nephew
Andover, MA
KEELY ZIPP
Director, Commercial Analytics
Incyte Corp.
Wilmington, DE
THOMAS ZIPP
Marketing Leader, BRILINTA
AstraZeneca Pharmaceuticals
Wilmington, DE
GEOFFREY M. GARRETT, PH.D.
Dean,
The Wharton School
HOWARD KAUFOLD, PH.D.
Vice Dean and Director,
The Wharton Graduate Division
SCOTT E. HARRINGTON, PH.D.
Chair,
Health Care Management Department, The Wharton School;
Director,
MBA Program in Health Care Management
JUNE M. KINNEY, M.A.
Associate Director,
MBA Program in Health Care Management
CHRISTINE ALESZCZYK
Administrative Coordinator,
MBA Program in Health Care Management
JANICE SINGLETON
Administrative Coordinator,
MBA Program in Health Care Management
Administration
38
The Program Faculty are drawn from
the Wharton School, the School of
Medicine, the School of Nursing, and
the School of Arts and Sciences at the
University of Pennsylvania and leading
health institutions in Philadelphia.
Additional support is provided by the
Fellows and Associates of the Leonard
Davis Institute of Health Economics.
ABBY E. ALPERT, PH.D.
Assistant Professor,
Health Care Management,
The Wharton School
EUGENIO ANESSI, PH.D.
Professor, Public Management,
Bocconi University Graduate School
of Management, Milan, Italy;
Lecturer and Senior Fellow,
Health Care Management,
The Wharton School
DAVID A. ASCH, M.D., M.B.A.
Executive Director,
Penn Medicine Center for Health
Care Innovation;
Professor of Medicine,
Perelman School of Medicine
at the University of Pennsylvania;
Professor, Health Care Management,
The Wharton School
THOMAS E. BAKER, J.D.
William Maul Measey Professor of
Law and Health Sciences, University
of Pennsylvania Law School;
Professor of Health Care Management,
The Wharton School
LAWTON R. BURNS, PH.D., M.B.A.
James Joo-Jin Kim Professor of Health
Care Management, The Wharton School;
Faculty Co-Director,
Roy and Diana Vagelos Program
In Life Sciences & Management
PATRICIA M. DANZON, PH.D.
Celia Z. Moh Professor Emeritus
of Health Care Management,
The Wharton School
GUY DAVID, PH.D.
Associate Professor,
Health Care Management,
The Wharton School
BENJAMIN DORANZ, PH.D., M.B.A.
President and CEO, Integral Molecular,
Inc.; Senior Fellow, Health Care
Management, The Wharton School
EZEKIEL J. EMANUEL, M.D., PH.D.
Diane v.S. Levy and Robert M.
Levy University Professor and
Vice Provost for Global Initiatives;
Professor, Health Care Management,
The Wharton School
BRADLEY M. FLUEGEL
Senior VP & Chief Strategy
Officer, Walgreens;
Lecturer, Health Care Management,
The Wharton School
THOMAS N. GILMORE, M.ARCH.
Vice President,
The Center for Applied Research Inc.;
Senior Fellow, Health Care Management,
The Wharton School
JOHN P. GLASER, PH.D.
Senior Vice President, Client
Administration, Cerner Corporation;
Lecturer, Health Care Management
The Wharton School
HENRY A. GLICK, PH.D.
Professor of Medicine,
Perelman School of Medicine at
the University of Pennsylvania;
Professor, Health Care Management,
The Wharton School
MATTHEW R. GRENNAN, PH.D.
Assistant Professor,
Health Care Management,
The Wharton School
SCOTT E. HARRINGTON, PH.D.
Chair, Health Care Management
Department, and Director,
Health Care Management Program,
The Wharton School
Alan B. Miller Professor of Health Care
Management and Business Economics
and Public Policy, The Wharton School
ERIC M. HEIL
SVP, Chief Commercial Officer
Software Solutions, NaviHealth, Inc.;
Lecturer, Health Care Management,
The Wharton School
JOHN C. HERSHEY, PH.D.
Anheuser-Busch Professor Emeritus
of Management Science; and
Health Care Management,
The Wharton School
JOHN KIMBERLY, PH.D.
Henry Bower Professor of Entrepreneurial
Studies; Professor of Management,
Health Care Management, and Sociology,
The Wharton School
JUNE M. KINNEY, M.A.
Associate Director, Graduate Program
in Health Care Management;
Lecturer, Health Care Management,
The Wharton School
GARY J. KURTZMAN, M.D.
Vice President, Life Sciences,
Safeguard Scientifics; Lecturer,
Health Care Management,
The Wharton School
JEFFREY P. LIBSON, J.D.
Partner, Pepper Hamilton LLP;
Lecturer, Health Care Management,
The Wharton School
HARI MAHADEVAN, PH.D.
Independent Consultant;
Lecturer and Senior Fellow,
Health Care Management,
The Wharton School
STEVEN A. NICHTBERGER, M.D.
Adjunct Professor and Senior Fellow,
Health Care Management,
The Wharton School
MITESH S. PATEL, M.D.
Assistant Professor of Medicine, Perelman
School of Medicine at the University
of Pennsylvania School of Medicine;
Assistant Professor of Health Care
Management, The Wharton School
MARK V. PAULY, PH.D.
John M. and Thomas L. Bendheim
Professor; Professor, Health Care
Management, Business Economics and
Public Policy, The Wharton School;
Professor, Economics, College of Arts
and Sciences
WILLIAM P. PIERSKALLA, PH.D.
Professor Emeritus
DANIEL POLSKY, PH.D.
Robert D. Eilers Professor of Health Care
Management and Economics,
The Wharton School;
Professor of Medicine,
Perelman School of Medicine
at the University of Pennsylvania;
Executive Director, Leonard Davis
Institute of Health Economics
Faculty
39
DOUGLAS A. PRESENT, M.B.A.
Investor and Advisor;
Lecturer, Health Care Management,
The Wharton School
ARNOLD J. ROSOFF, J.D.
Professor Emeritus,
Legal Studies and Business Ethics;
Lecturer, Health Care Management,
The Wharton School
STEPHEN M. SAMMUT
Lecturer and Senior Fellow,
Health Care Management,
Lecturer, Entrepreneurial Programs,
The Wharton School
CYNTHIA SCALZI, M.N., PH.D.
Professor Emeritus of Nursing
and Health Care Management,
The Wharton School
J. SANFORD SCHWARTZ, M.D.
Leon Hess Professor in Internal
Medicine, Perelman School of Medicine
at the University of Pennsylvania;
Professor, Health Care Management,
The Wharton School
JEFFREY H. SILBER, M.D., PH.D.
Director, Center for Outcomes Research,
The Children’s Hospital of Philadelphia;
Professor of Pediatrics and
Anesthesiology & Critical Care,
Perelman School of Medicine at
the University of Pennsylvania;
Professor, Health Care Management,
The Wharton School
JEFFREY A. SOLOMON, M.D., M.B.A.
Founding Partner, Infiniti Medical LLC;
Lecturer, Health Care Management,
The Wharton School
ASHLEY SWANSON, PH.D.
Assistant Professor,
Health Care Management,
The Wharton School
KEVIN G.M. VOLPP, M.D., PH.D.
Director, Center for Health Incentives
and Behavioral Economics,
Leonard Davis Institute;
Professor of Medicine,
Perelman School of Medicine
at the University of Pennsylvania;
Professor, Health Care Management,
The Wharton School
SCOTT E. HARRINGTON, PH.D.
Director,
MBA Program in
Health Care Management,
The Wharton School
JUNE KINNEY
Associate Director, MBA Program
in Health Care Management
The Wharton School
The University of Pennsylvania
values diversity and seeks talented
students, faculty and staff from diverse
backgrounds. The University of
Pennsylvania does not discriminate
on the basis of race, sex, sexual
orientation, gender identity, religion,
color, national or ethnic origin, age,
disability, or status as a Vietnam Era
Veteran or disabled veteran in the
administration of educational policies,
programs or activities; admissions
policies; scholarship and loan awards;
athletic, or other University adminis-
tered programs or employment.
Questions or complaints regarding
this policy should be directed to:
Executive Director,
Office of Affirmative Action
and Equal Opportunity Programs
Sansom Place East
3600 Chestnut Street, Suite 228
Philadelphia, PA 19104-6106
215.898.6993 (Voice)
215.898.7803 (TDD)
©2004, The Trustees of
the University of Pennsylvania.
All rights reserved.
Photography of Students: adamgierkephotography.com
Book Design: www.HollisterCreative.com
RACHEL M. WERNER, M.D., PH.D
Associate Professor of Medicine,
Perelman School of Medicine at the
University of Pennsylvania School of
Medicine; Associate Professor and Senior
Fellow, Operations and Information
Management, Health Care Management,
The Wharton School
JOHN J. WHITMAN, M.B.A.
Executive Director, The TRECS Institute;
Lecturer, Health Care Management,
The Wharton School
SANKEY V. WILLIAMS, M.D.
Professor of General
Internal Medicine; Professor,
Health Care Management,
The Wharton School
Wharton
The Wharton School
University of Pennsylvania
MBA Program in Health Care Management
3641 Locust Walk
Philadelphia, PA 19104-6218
215.898.6861
fax 215.573.2157
